Where the heat goes.
Almost every surgical energy device does one thing to tissue: it raises the temperature for a controlled time. So why does surgery need eleven different energies, and what does it take to put that effect exactly where the surgeon intends, and nowhere else?
Before we start.
Most introductions to surgical energy are catalogs. There is the electrosurgical pencil that cuts and coagulates, the bipolar sealer that closes vessels, the ultrasonic shears that do both, the lasers, and a separate shelf of ablation systems that destroy tumors with heat, cold, microwaves or electric pulses. Each entry comes with what it is for and which company makes it. The catalog is accurate and it explains almost nothing. It does not say why one generator needs five different waveforms to cut and to coagulate, why a blade that is never sharp can divide tissue, why a microwave antenna outpaces an RF needle, or why some ablation energies spare the vessels running through the tissue they kill.
This guide is built around one question instead: almost every surgical energy device does one thing to tissue, which is to raise its temperature for a controlled time, so why does surgery need eleven different energies, and what does it take to put that effect exactly where the surgeon intends, and nowhere else?
The eleven are monopolar radiofrequency (RF) electrosurgery, conventional bipolar RF, advanced bipolar vessel sealing, ultrasonic dissection, surgical lasers, RF ablation, microwave ablation, cryoablation, pulsed electric fields (irreversible electroporation and pulsed field ablation), thermal focused ultrasound, and histotripsy. Hybrid instruments combine two of them in one jaw.
Here is the short answer, which the rest of the guide exists to justify. Tissue responds to heat by one rule: injury accumulates with temperature and time, so ten degrees can change the time needed a thousandfold, and at 100 °C the water in cells boils. The energies do not differ much in what they finally do to tissue. They differ in where they deposit energy and how fast. Current heats wherever it is most concentrated, which is at the tip of a small electrode. A vibrating blade heats at its own face. Light heats a layer whose depth the wavelength sets, from a micron to several millimeters. A microwave field heats a volume around an antenna, focused sound heats a point deep inside a closed body, and a cryoprobe takes heat away. Two of the eleven, pulsed electric fields and histotripsy, kill cells without relying on heat at all, because for some tasks heat's side effect, destroying the collagen of vessels and ducts, is the problem. Each surgical task needs a different geometry and a different time scale, and that is why there are eleven.
The second half of the question is engineering. A generator must hold its output across a hundredfold range of tissue impedance. The current it sends into the patient must return without burning anything on the way. An instrument must not leak energy outside the camera's view, and the smoke, light and heat it releases must be managed in a room full of oxygen and people. Then the device must prove all of this, to standards and to regulators, before anyone may sell it.
One physical fact runs through every chapter. Heat spreads through tissue a distance that grows with the square root of time: about three quarters of a millimeter in one second, about two and a half millimeters in ten. Energy delivered faster than heat can spread stays where it was put; energy delivered slowly spreads with it. Every device in this guide is, at bottom, a way of controlling where energy lands and how quickly it arrives.
How to read this guide
Chapters are numbered straight through, and each one opens with the question a careful reader would ask after the previous chapter. Plates are numbered separately so that any one can be cited on its own. Four kinds of box recur:
Blue edge. Carries the structural point of a section, or a worked calculation.
Orange edge. Names a common misreading, a trap, or the limit of a claim.
Green edge. Maps the idea onto the reader's own work: in instrument and generator design, at the test bench, or in a regulatory file.
- Each chapter closes with what it established, in three or four lines.
The mathematics stays at Ohm's law, power, ratios, squares and square roots, and powers of ten. Where a number is derived, the arithmetic is shown once with real values and the assumptions are stated. Generator circuits are drawn as block diagrams, not schematics. Where a plate is schematic rather than data, it says so.
Inside the plates, color is a legend and never decoration. Electrical current and fields, sound and vibration, light, heat and its effects, and cold each have one color throughout the guide. The measured readout is always blue, and one orange mark in each plate points at the detail that matters most. A key strip under every plate lists only the colors that plate uses.
This is a reference for understanding, not a surgical technique, an engineering specification, a regulatory opinion or clinical advice. Regulatory status, standards editions and product details are stated as of September 2026 and will date. Where a figure is a manufacturer's claim or comes from a manufacturer-authored study, the text says so. Named products are examples of a principle, not recommendations.
+ Part I · Physics
The physics of energy in tissue.
Every energy in this guide reaches the same destination, a change in tissue, by a different road. These six chapters build the physics the rest of the book leans on: how temperature and time decide what happens to a cell, how heat spreads and what carries it away, why tissue conducts current and why surgical current alternates so fast, and what sound and light do when they enter the body. The last chapter lines up the carriers side by side. Nothing here assumes more than school physics.
Degrees and seconds.
+ The questionWhy does the same tissue bleed, seal, char or vaporize depending on a few degrees and a few seconds?
Heat unfolds proteins
Temperature is a measure of how violently molecules move. In tissue at 37 °C, that motion is gentle enough for proteins to keep their shapes, and a protein's shape is its function. An enzyme works because its folded chain puts a few chemical groups in exactly the right places; a collagen fiber is strong because three chains wind around each other like a rope. Those shapes are held by a great many weak interactions, among them hydrogen bonds between neighboring parts of the chain and the clustering of oily side chains away from water, while the backbone of each chain is held by much stronger covalent bonds.
Adding heat adds motion. As tissue warms, the weak bonds are the first to shake loose, and the protein unfolds while its backbone survives. The unfolded chains then tangle with their neighbors, which is why a heated egg white turns from clear to opaque and does not turn back. In tissue the same change is called coagulation: the tissue blanches, stiffens and stops working, and its cells are dead even if they are still in place.
Collagen matters more than any other protein in this guide. It gives vessel walls, skin and tendons their strength, and it behaves in a characteristic way when heated. Its triple helix unwinds over a band of temperatures that published measurements put between about 55 and 80 °C, depending on the tissue and the test, and the fiber shrinks as it does so. If two layers of unwound collagen are pressed together while they cool, their strands entangle across the boundary and the layers fuse. That is the mechanism of a vessel seal, and Chapter 9 builds on it.
Damage is a rate, not a threshold
It is tempting to picture a temperature at which tissue dies, but heat damage does not work like a switch. Unfolding a protein is a chemical reaction, and like most reactions it runs at a rate that climbs steeply with temperature. The standard description is the Arrhenius model: the rate of damage rises exponentially as temperature rises, and damage accumulates for as long as the temperature is held. The same injury can therefore come from a lower temperature held for a long time or a higher one held briefly.
Hyperthermia researchers capture this with a thermal dose called CEM43, the number of cumulative equivalent minutes at 43 °C. Above 43 °C, each additional degree halves the time needed for the same effect. A widely used threshold for tissue damage is 240 equivalent minutes, and the arithmetic shows how quickly the time collapses as temperature rises.
At 43 °C, 240 minutes. Each degree above 43 °C halves the time, so at 45 °C it is 240 ÷ 2² = 60 minutes, at 47 °C it is 15 minutes, and at 50 °C it is 240 ÷ 2⁷ ≈ 1.9 minutes. At 60 °C it is 240 ÷ 2¹⁷ minutes, about 0.11 seconds. Ten degrees, from 50 to 60 °C, shorten the time by 2¹⁰, roughly a thousandfold.
The halving rule is a good description of some tissues and a poor one of others. Arrhenius coefficients fitted to skin predict that each degree roughly halves the time, as CEM43 does. Coefficients fitted to liver are shallower: each degree speeds the damage by only 25–40 %. A rat-liver data set predicts about six minutes at 50 °C, 30 seconds at 60 °C and three seconds at 70 °C, which is far slower at 60 °C than the skin data. The skin and liver data sets agree near 50 °C, at about six minutes, and diverge above it.
For the rest of this guide, two consequences matter. First, a device that controls temperature within a few degrees controls its effect within a factor of several, so small errors in temperature are large errors in dose. Second, the familiar rule that "proteins coagulate almost instantly at 60 °C" is only approximately true. In one tissue it takes a fraction of a second; in another it takes tens of seconds.
Any sentence of the form "tissue dies at X °C" hides a time. Published values for the onset of coagulation range from about 50 to 60 °C because they come from different tissues, species and exposure times. When comparing devices, compare temperature and time together, or better, the measured zone of damage.
Water turns 100 °C into a wall
Soft tissue is mostly water: about 77 % in liver and 75 % in muscle. Water has an unusual property that shapes almost everything electrosurgery does. Raising its temperature takes a moderate amount of energy, but turning it into steam takes a great deal more.
Take one gram of tissue that is 75 % water, with a specific heat of about 3.6 joules per gram per degree. Heating it from 37 to 100 °C takes 3.6 × 63 ≈ 227 J. Boiling off its water then takes 0.75 g × 2,257 J/g ≈ 1,693 J, about seven and a half times as much. For pure water the ratio is 8.6.
That ratio has three consequences. The first is that wet tissue has a built-in thermostat. While liquid water remains, energy goes into boiling it rather than into raising the temperature, so the temperature stalls near 100 °C. A generator that keeps tissue wet keeps it near 100 °C no matter how much power it delivers; the extra energy only boils water faster.
The second consequence is cutting. If energy arrives in a thin layer faster than steam can escape, the water inside each cell flashes to vapor and the cell bursts. Measurements in electrosurgery put the onset of this vaporization between 100 and 110 °C. A moving line of bursting cells is an incision, and Chapter 8 shows how an electrode produces one without being sharp. If the same energy arrives slowly, the water leaves gradually instead, and the tissue dries and shrinks into a firm coagulum. This is desiccation, and it is how most contact coagulation works.
The third consequence appears when the water is gone. Nothing then holds the temperature down, and dry tissue heats quickly. Once dry, it begins to carbonize: sources put the onset anywhere from just above 100 °C to above 300 °C, and a defensible summary is about 150–200 °C once the tissue has dried out. Char is almost always unwanted. It wastes energy, releases smoke, and, as Chapter 13 will show, conducts current poorly, which stalls any further heating by current.
Every thermal injury has the same anatomy
Because temperature falls with distance from the source, every thermal device leaves the same nested pattern in tissue. Nearest the source, the hottest tissue has vaporized and is gone. Around the crater lies a thin layer of char, where the tissue dried and then carbonized. Next comes a desiccated band, heated to about 90–100 °C, where water was driven off. Outside that is the coagulated zone, from about 90 °C down to 50–60 °C at its edge, depending on how long it was held, where proteins and collagen have denatured and the cells are dead. The outermost band reached only 43–50 °C, and its cells may recover or may die over the following hours.
The devices in this guide differ mainly in how thick they make each band. A short laser pulse can leave a crater with almost no coagulated tissue beneath it. A slow contact coagulation leaves a thick coagulated band and no crater at all. A vessel sealer aims for a fused band of coagulated collagen and as little else as possible.
The boundary that matters clinically is the outer edge of the coagulated zone, the margin of irreversible injury. It is not reliably visible at the time of surgery. Coagulated tissue can look almost normal when the instrument is withdrawn, then die and weaken over the following days. This is why a thermal injury to bowel can be missed during an operation and present days later, a pattern Chapter 18 returns to.
Four effects, one map
With temperature and time in hand, the tasks surgeons ask of energy fall onto one map. Coagulation stops bleeding from small vessels by heating tissue to 60–100 °C for seconds, shrinking vessel walls and clotting blood. Sealing does the same to a vessel held closed under pressure, so that its collagen fuses into a band strong enough to replace a suture. Cutting delivers energy so quickly into a thin line that the water boils explosively and the tissue parts. Ablation kills a volume of tissue in place, usually a tumor, by holding it above about 60 °C for seconds to minutes, or by freezing it.
Char appears on none of those lines. It is the sign of energy delivered after the water had gone, and a well-controlled device avoids it. The difference between a clean cut and a charred one, or between a seal and a burn, is almost always a difference in how fast energy arrived and when it stopped.
A specification that states only a temperature, "the jaw reaches 90 °C", says little about the effect. State temperature and time together, or specify the effect directly: the width of the coagulated zone, the burst pressure of a seal, the depth of an incision. That is also what regulators ask for. FDA's guidance for electrosurgical devices expects the thermal damage zone to be measured in tissue by histology, not inferred from a temperature alone.
- Heat unfolds proteins by breaking weak bonds; collagen unwinds and shrinks between about 55 and 80 °C and fuses under pressure.
- Thermal damage is a rate: above 43 °C each degree roughly halves the time for the same injury, though liver is less steep than skin.
- Boiling water takes about seven and a half times the energy of heating tissue to 100 °C, so wet tissue stalls at 100 °C, fast heating cuts, slow heating desiccates, and only dry tissue chars.
- Every thermal injury has nested zones; the outer edge of coagulation is the margin that matters and it is not reliably visible at the time.
How heat moves.
+ The questionIf energy is deposited in one small place, why does the damage spread beyond it, and what carries the heat away?
Heat flows downhill, slowly
Chapter 1 treated each point of tissue as if it kept whatever heat it received. It does not. Heat flows from hotter tissue to cooler tissue, at a rate set by the temperature difference and by the tissue's thermal conductivity. Soft tissue conducts heat about as well as water does: about 0.5 watts per meter per degree for liver, against 0.6 for water at room temperature. That makes tissue a poor conductor. Copper conducts heat about 800 times better.
What decides how fast a temperature disturbance spreads is not conductivity alone but conductivity divided by how much heat each unit of volume can store. The ratio is the thermal diffusivity, and for water and most soft tissues it is about 0.14 square millimeters per second. The number looks abstract, but it answers the practical question of how far heat travels in a given time.
The square-root rule
A pulse of heat deposited at a point does not travel outward at a steady speed, the way sound does. It diffuses, and diffusion covers distance in proportion to the square root of time. A convenient estimate of how far heat has spread after a time t is the diffusion length, √(4αt), where α is the diffusivity.
With α = 0.14 mm²/s: after 0.1 s, √(4 × 0.14 × 0.1) ≈ 0.24 mm. After 1 s, √0.56 ≈ 0.75 mm. After 10 s, √5.6 ≈ 2.4 mm. After a minute, about 5.8 mm. A hundred times longer reaches only ten times farther.
This single relationship explains a great deal of surgical practice. Energy delivered in a fraction of a second stays within a fraction of a millimeter of where it was put, because heat has had no time to move. Energy delivered over ten seconds has had time to reach tissue two or three millimeters away. A device that wants a narrow effect, a clean incision or a precise laser crater, must deliver its energy quickly. A device that wants a broad effect, such as coagulating a wide area or ablating a tumor, can take its time and let conduction do part of the work.
The same rule sets the thermal spread of a vessel seal. A sealing cycle takes two to four seconds, and the diffusion length over that time is roughly one to one and a half millimeters. A manufacturer-authored study of three current sealers reports lateral thermal spread of about 1.3–2.1 mm in vivo, the same order as the square-root rule predicts.
Heat also keeps moving after the energy stops. A hot jaw or blade continues to conduct heat into whatever it touches, and a heated zone continues to spread until its temperature falls. The damage a device causes can therefore grow for a few seconds after activation ends. Chapter 11 shows why this matters most for ultrasonic instruments.
Blood carries heat away
Conduction is not the only way heat leaves a heated zone. Living tissue is threaded with capillaries, and blood entering at 37 °C picks up heat and carries it away. The standard description is the Pennes bioheat equation of 1948, and in words it is a simple budget. The temperature of a small volume of tissue rises by the heat the source deposits in it, minus the heat conducted to its neighbors, minus the heat carried off by blood. Metabolic heat is also in the equation, but during surgery it is negligible.
The blood term varies more than any other. Resting skeletal muscle receives about 4 milliliters of blood per minute for every 100 grams of tissue; liver about 95; kidney about 460. The same device, delivering the same power, therefore heats kidney less than muscle, and any model or bench test that ignores perfusion will overestimate heating in well-perfused organs. FDA guidance asks for thermal testing in several tissue types, and perfusion is one more reason that tests in dead, unperfused tissue need interpreting with care.
Heating also changes the budget as it proceeds. Inside a coagulated zone the capillaries thrombose and blood stops flowing, so the cooling term vanishes there and heating accelerates. The tissue's properties shift too: its electrical conductivity rises by about 2 % for every degree, which matters for any energy delivered as current, and its thermal properties change as it dries.
The heat sink
Capillaries cool tissue a little everywhere. A large vessel cools it a lot in one place. Blood flowing through a vein several millimeters wide holds the vessel wall close to 37 °C against all but intense heating, and the tissue immediately around it stays cooler than tissue farther away. Surgeons and engineers call this the heat sink effect.
The effect is strongest in ablation, where the goal is to kill every cell in a volume. In a study of RF ablation in pig liver, the ablation zone was deformed by 73 % of veins wider than 3 mm and by none of the smaller ones, and viable cells remained around every vein wider than 5 mm. In patients treated with RF ablation for liver tumors, treatment was incomplete or the tumor recurred in 48 % of tumors that touched a vessel of 3 mm or more, against 7 % of those that did not. The "3 mm rule" in ablation practice comes from this work.
The heat sink is not always an enemy. It protects large vessels running near a heated zone, which is one reason tumors next to major vessels can be ablated at all. And it is one more reason a vessel sealer clamps its vessel shut: with flow stopped inside the jaw, the vessel's own blood can no longer carry the heat away.
Most bench tests of thermal devices use excised tissue with no blood flow. They show the zone a device makes when no blood carries heat away, usually larger than in living tissue, but not what happens next to a perfused vessel. Chapter 13 returns to this for ablation; microwave energy reduces the heat sink but does not remove it.
Lateral thermal spread
The practical measure of all of this is lateral thermal spread: how far thermal damage extends beyond the tissue the device was meant to affect. It is measured after the fact, by cutting the tissue, staining it and measuring the damaged zone under magnification. FDA's electrosurgical guidance asks for exactly that: the length, width and depth of the thermal damage zone in at least three tissues, such as liver, kidney and muscle, measured in triplicate at the minimum, default and maximum settings.
Spread depends on everything in this chapter: how much energy the device delivers, how fast, into which tissue, with how much blood flow, and for how long it stays hot afterwards. It is the single number that best summarizes whether a device put its effect where the surgeon intended, and it recurs in every chapter on instruments.
When comparing thermal spread figures, check the conditions. Spread measured in excised tissue at a short activation says little about a long activation in perfused tissue. The comparisons that mean something use the same tissue, the same vessel sizes, the same settings and activation times, and histology rather than surface appearance.
- Soft tissue conducts heat about as well as water; its thermal diffusivity is about 0.14 mm²/s.
- Heat spreads a distance of √(4αt): about 0.24 mm in 0.1 s, 0.75 mm in 1 s and 2.4 mm in 10 s, so fast energy stays local.
- Blood carries heat away in proportion to perfusion, which varies about a hundredfold between tissues; large vessels act as heat sinks.
- Lateral thermal spread, measured by histology, is the practical summary of where a device's heat actually went.
Tissue as a conductor.
+ The questionWhy does current heat tissue at all, and why must surgical current alternate hundreds of thousands of times a second?
Tissue conducts with ions
A metal conducts because some of its electrons are free to move. Tissue has no free electrons. It conducts because it is salt water: sodium, potassium and chloride ions dissolved in the fluid inside and between cells carry charge when a voltage pushes them. Anything that changes how many ions there are, or how freely they can move, changes how well a tissue conducts.
The differences between tissues are large. At 500 kHz, a typical electrosurgical frequency, published tissue models give blood a conductivity of about 0.75 siemens per meter, muscle 0.45, kidney 0.23 and liver 0.15. Fat, which holds little water, conducts at about 0.025, eighteen times less than muscle, and dry skin at about 0.004. Physiological saline at body temperature conducts at about 1.9, roughly ten times better than liver. Measurements on living liver are reported to be higher than those on excised tissue, so a fair range for liver is 0.1–0.4 S/m depending on the source and its condition.
These values explain where current goes inside a patient. Given a choice of paths, current divides in proportion to how well each path conducts, so it crowds into wet, lean tissue, blood and saline, and avoids fat and dry skin. A pool of saline irrigation around an electrode can carry current away from the tissue it was meant to heat.
How current becomes heat
When current flows through a resistor, it heats it. The power is familiar from school physics: P = I²R, or equivalently P = V²/R, where I is current, V is voltage and R is resistance. Inside tissue it is more useful to think per unit volume. The heat deposited in each cubic millimeter is the square of the local current density, J, divided by the local conductivity: J²/σ. That is Joule heating, and it is how every RF device in this guide heats tissue.
The formula has a consequence that surprises people. For a given current density, a poor conductor heats more; for a given electric field, a good conductor heats more. Which view applies depends on whether the current or the voltage is being held fixed, and Chapter 10 shows that a generator switches between the two as tissue changes.
Current density decides where the heat appears
The single most important idea in electrosurgery is that heating follows current density, and current density depends on geometry. Current leaving a small electrode must spread out through a steadily larger area of tissue. Around a small sphere, the area at distance r grows as r², so the current density falls as 1/r². Heating goes with the square of current density, so it falls as 1/r⁴.
Take 0.5 A flowing out of a small spherical electrode into muscle, taking its conductivity as 0.4 S/m. At 1 mm from the center the current density is 0.5 ÷ (4π × 0.1² cm²) ≈ 4 A/cm², a power density J²/σ of about 4 kW per cubic centimeter. With a heat capacity of about 3.8 J per cubic centimeter per degree, the tissue there heats at about 1,000 °C per second before any heat conducts away. At 2 mm the current density is a quarter as large, 1 A/cm², and heating is a sixteenth, about 65 °C per second. At 4 mm it is about 4 °C per second; at 10 mm about 0.1 °C per second.
The fall-off is so steep that heat appears only where current is concentrated. At the tip of an electrosurgical pencil, a fraction of a square millimeter carries the whole current and tissue boils in milliseconds. The same current leaving the patient through a return pad of tens of square centimeters warms the skin by a few degrees. Nothing in the circuit is different except area.
The same principle explains most of the failures in Part VII. Any place where current is forced through a small area becomes, in effect, an electrode: the edge of a return pad that is peeling, a pinhole in an instrument's insulation, the point where a shaft touches bowel. The physics does not know which small area the surgeon intended.
Cells are tiny capacitors
So far tissue has been treated as a uniform conductor. On the scale of cells it is not. Each cell is wrapped in a membrane only a few nanometers thick that is an excellent electrical insulator, with conducting fluid on both sides. A thin insulator between two conductors is a capacitor, and so each cell membrane behaves as one.
A capacitor blocks steady current but passes alternating current, and it passes more the faster the current alternates. At low frequency, the membranes block current, which flows only through the fluid between cells. As frequency rises, the membranes pass more and more of it, and current flows through the cells as well as around them. Tissue models show this directly: between 100 kHz and 1 MHz, muscle's conductivity rises from about 0.36 to 0.50 S/m, while its permittivity, the measure of how much charge its membranes store, falls from about 8,000 to 1,800.
Why the current must alternate so fast
The capacitor picture also explains why surgical current is alternating current at hundreds of kilohertz. A nerve or muscle cell fires when the voltage across its membrane changes by enough, for long enough. Direct current, or mains current at 50 or 60 Hz, pushes one way for milliseconds at a time, long enough to charge membranes fully and to fire nerves and contract muscles, including the heart.
Raise the frequency and each half-cycle becomes shorter than the time a membrane needs to charge and a nerve needs to respond. Nerve cells need a stimulus lasting about 0.1–10 milliseconds; at 400 kHz, one half-cycle lasts 1.25 microseconds. The current still flows and still heats, but it no longer stimulates.
The French physiologist Jacques-Arsène d'Arsonval showed this in 1891, when he found that the muscular response to alternating current faded as he raised the frequency and had all but disappeared at about 10 kHz, the highest his equipment could reach. He reported passing about 0.8 A through his own body at high frequency and feeling nothing but warmth. Modern generators work far above his limit. IEC 60601-2-2, the safety standard for electrosurgical equipment, defines their high-frequency range as generally above 200 kHz and below 5 MHz, and most run between 300 and 500 kHz.
There is also a reason not to go much higher. The current that flows through a capacitor rises in proportion to frequency, and every cable, instrument shaft and patient is surrounded by stray capacitance. At higher frequencies more current leaks away through those unintended paths, an effect Chapter 18 quantifies. The working band of a few hundred kilohertz is a compromise between stimulation at the low end and stray coupling at the high end.
When an electrode arcs, the arc conducts better in one direction than the other and partly rectifies the current, creating a small low-frequency component. That component can stimulate muscle. Generators place capacitors in series with their outputs to block direct and low-frequency current; these limit the effect but, as Chapter 8 shows, do not remove it entirely.
Two questions about any RF device follow from this chapter. Where is the current density highest, and is that where the heating is wanted? And what else in the circuit, including cables, shafts and the patient's contact with the table, offers current a small area or a capacitive path? Both appear, in different words, in the risk analysis every electrosurgical device must carry.
- Tissue conducts through ions; at 500 kHz conductivity ranges from about 0.75 S/m for blood to 0.025 S/m for fat.
- Current heats tissue as J²/σ, and near a small electrode heating falls as the fourth power of distance: twice as far, sixteen times less.
- Cell membranes are capacitors, so at high frequency current passes through cells and each half-cycle is too brief to fire a nerve.
- Surgical generators run generally above 200 kHz and below 5 MHz, mostly at 300–500 kHz, between nerve stimulation and stray coupling.
Sound in tissue.
+ The questionCurrent heats tissue because it pushes ions through it. How can a vibration heat tissue, cut it or tear it apart?
Sound is a traveling pressure wave
Sound is a mechanical wave. A vibrating surface pushes on the material next to it, compressing it; the compressed region pushes on the next, and a wave of alternating compression and rarefaction travels outward while each bit of material only oscillates back and forth about its place. In soft tissue that wave travels at about 1,540 meters per second, slightly faster than in water at 1,481 and far faster than in air at 343.
The wavelength is the speed divided by the frequency. At 1 MHz, a typical therapeutic frequency, it is 1.54 mm in tissue; at 4 MHz it is 0.39 mm. These lengths matter, because the finest detail a beam of sound can resolve or the smallest spot it can be focused to is of the order of one wavelength.
Surgery uses sound in two quite different regimes. Ultrasonic instruments vibrate a metal tip at 23–55.5 kHz, and the tissue that touches the tip is what they affect; the tip rubs, shears and churns tissue at its face. Focused ultrasound, at 0.7–4 MHz, sends a wave through intact skin and tissue to act at a point centimeters deep. The first regime is about friction and cavitation at a surface. The second is about how waves travel, reflect and are absorbed. This chapter builds both.
What happens at a boundary
Each material has an acoustic impedance, its density multiplied by its speed of sound, and sound crosses a boundary well only when the impedances on the two sides match. Soft tissue is about 1.63 megarayls and water 1.48, a close match. Cortical bone is about 7, with published values of 6–8. Air is about 0.0004, four thousand times lower than tissue.
The fraction of sound intensity reflected at a boundary is ((Z₂ − Z₁) ÷ (Z₂ + Z₁))². Between tissue and water it is 0.2 %. Between tissue and bone it is about 39 %. Between tissue and air it is 99.9 %: essentially everything bounces back.
Three practical consequences follow. A transducer must be coupled to the skin with gel or water, because even a thin layer of air would reflect almost all of its energy. A beam aimed through gas in bowel or lung is blocked, and a beam aimed through bone is partly reflected and partly absorbed, heating the bone; focused ultrasound therefore needs a clear acoustic window. And inside an ultrasonic instrument, the vibration stays in its metal waveguide because the gas around it is so poorly matched that almost nothing leaks out.
Absorption turns sound into heat
As sound travels through tissue, some of its energy is lost at every cycle to internal friction between moving molecules and structures, and that lost energy appears as heat; a little more is scattered. Soft tissue attenuates sound, mostly by absorption, by about 0.54 decibels per centimeter for every megahertz of frequency. A loss of 3 dB halves the intensity, so at 1 MHz the intensity halves in about 5.6 cm, and at 4 MHz in about 1.4 cm.
This sets the central trade of focused ultrasound. A lower frequency reaches deeper, but its longer wavelength focuses to a larger spot. A higher frequency focuses more finely but loses its energy sooner. A system that treats the prostate from inside the rectum, a few centimeters from its target, can use 4 MHz. The histotripsy system that treats liver tumors through the abdominal wall uses 700 kHz. Chapter 16 describes both.
Friction at a vibrating tip
An ultrasonic instrument's blade vibrates along its length with an excursion of 50–100 micrometers, tens of thousands of times a second. Those numbers hide extreme motion. If 100 µm is the full stroke at 55.5 kHz, the tip's peak speed is about 17 meters per second and its peak acceleration about six million meters per second squared, more than 600,000 times gravity.
Tissue pressed against such a surface is sheared and rubbed at high speed. Friction at the interface and internal losses in the deformed tissue turn the mechanical energy into heat, concentrated where the tissue touches the blade. As in Chapter 1, the proteins unfold and form a sticky coagulum that can seal small vessels, and with enough pressure and energy the tissue parts along the blade. No current flows through the patient: the transducer is driven electrically inside the handpiece, and only vibration leaves it. Chapter 11 follows the whole instrument.
Cavitation
The rarefaction half of each acoustic cycle pulls on the liquid in tissue. If the pull is strong enough, small gas bubbles can grow in it, and the way those bubbles behave divides into two kinds.
In stable cavitation, a bubble oscillates gently in size in step with the wave, swelling a little in each rarefaction and shrinking in each compression. In inertial cavitation, a bubble grows, within one cycle or over several, to many times its size and then collapses violently, focusing its energy into a tiny volume and launching a shock wave. The collapse is what damages tissue.
Two surgical tools exploit cavitation on purpose. Ultrasonic aspirators, which vibrate a hollow tip at 23 or 36 kHz, create cavitation in front of the tip, about 100–200 µm ahead of its rim, which, with direct mechanical cutting, fragments tissue with high water content and weak cohesion while sparing collagen-rich structures such as vessels, nerves and ducts. Histotripsy, in Chapter 16, generates inertial cavitation deep inside the body with focused pulses. For single-cycle pulses, cavitation starts even without a seed bubble once the peak negative pressure exceeds about 25–30 megapascals, a threshold that measurements show is nearly the same across soft tissues and frequencies.
Sound can act on tissue in three ways, and each is a different device. Absorbed along its path, it heats: that is thermal focused ultrasound. Rubbed against tissue by a vibrating surface, it heats by friction at that surface: that is the ultrasonic shear. Pulled hard enough in the negative half of a cycle, it makes bubbles that tear tissue mechanically: that is the aspirator and histotripsy.
Cavitation damages tissue mechanically, with little heating, and it is easy to conclude that a device using it is gentle. The energy is still there; it is simply delivered as pressure rather than heat. Whether that spares a structure depends on the structure's mechanical strength, which is why collagen-rich vessels survive and water-rich parenchyma does not.
- Sound travels through tissue at about 1,540 m/s; its wavelength at 1 MHz is about 1.5 mm, which limits how finely it can focus.
- Boundaries reflect sound more strongly the larger the impedance mismatch: 0.2 % at tissue and water, about 39 % at bone, 99.9 % at air.
- Tissue attenuates sound by about 0.54 dB per centimeter per megahertz, so higher frequencies focus finely but reach less deep.
- Vibrating tips heat tissue by friction at their surface; cavitation tears tissue mechanically, above about 25–30 MPa negative pressure without a seed bubble.
Light in tissue.
+ The questionWhy does light from one laser stop within a hundredth of a millimeter of the surface, while light from another reaches several millimeters deep?
Absorbers and scatterers
Light entering tissue meets two kinds of obstacle. Some molecules absorb it, taking the photon's energy and turning it into heat. These absorbers are called chromophores, and in surgery three matter most: water, which is everywhere; hemoglobin, in blood; and melanin, in pigmented skin. Everything else in tissue, the cell membranes, fibers and organelles, mostly scatters light, bending it in new directions without absorbing it.
How strongly a chromophore absorbs depends on wavelength, often enormously. Water is almost perfectly transparent to green light and almost opaque to much of the infrared. Hemoglobin absorbs green light strongly and near-infrared light weakly. A laser emits one wavelength, so choosing a laser is choosing which chromophore will do the absorbing, and therefore where the heat will appear.
The Beer–Lambert rule
For absorption alone, light intensity falls exponentially with depth: I = I₀ e^(−µaz), where µa is the absorption coefficient, the probability of absorption per centimeter. The depth at which the intensity has fallen to about 37 % is 1/µa, the absorption depth. Most of the light's energy, and so most of the heat, is deposited within that depth.
For water, published absorption coefficients span nearly eight orders of magnitude across the surgical wavelengths. At the 10.6 µm wavelength of a carbon dioxide laser, water absorbs about 855 per centimeter, so the absorption depth is about 12 µm. At 532 nm, green light from a KTP laser, water absorbs about 0.00044 per centimeter, an absorption depth of more than twenty meters.
Water rules the infrared beyond 1.4 µm
Most surgical lasers work in the infrared, where water absorbs strongly, so their depth follows almost directly from water's absorption. Tissue is about 75 % water, which lengthens the depth slightly compared with pure water.
| Laser | Wavelength | Water absorption (per cm) | Absorption depth in tissue |
|---|---|---|---|
| Er:YAG | 2.94 µm | about 12,500 | about 1 µm |
| CO₂ | 10.6 µm | about 855 | about 16 µm |
| Thulium fiber | 1.94 µm | about 120 | about 0.11 mm |
| Diode | 1.47 µm | about 29 | about 0.47 mm |
| Ho:YAG | 2.1 µm | about 27 | about 0.5 mm |
The table explains a laser's character. An Er:YAG laser deposits its energy within about a micron of the surface, so it removes tissue in thin layers with very little heat left behind. A CO₂ laser deposits its energy in a layer about 16 µm deep and vaporizes it, which makes a precise incision but seals only the smallest vessels, because very little tissue is heated below the cut. Holmium and thulium lasers, absorbed within about half a millimeter and a tenth of a millimeter, both cut and coagulate, and because thulium's light is absorbed about four to five times more strongly than holmium's, thulium puts the same energy into a shallower layer.
Hemoglobin and scattering at shorter wavelengths
Toward the visible end of the spectrum, water stops absorbing and two other things take over. At 532 nm, oxygenated whole blood absorbs about 235 per centimeter, an absorption depth of about 43 µm, while the water around it is almost transparent. Green light therefore passes through water or saline irrigation and is absorbed by blood-filled tissue. That is the basis of KTP laser vaporization of the prostate, where the procedure runs under irrigation. Blood absorbs roughly 40–200 times more strongly at 532 nm than near 1,000 nm, depending on how oxygenated it is.
At 980 and 1,064 nm neither water nor hemoglobin absorbs strongly, and scattering dominates. Light is bounced around inside the tissue and spreads over millimeters before it is absorbed. Diode lasers at 980 nm and Nd:YAG lasers at 1,064 nm therefore coagulate deeply rather than cut precisely. Their depth is set by scattering, which varies with tissue, and published values are less consistent than for the water-absorbed lines.
The depths in the table are optical: where the light is absorbed. The thermal damage beneath an incision is usually deeper, because heat conducts outward from the absorbing layer during and after the pulse. A position paper on dental lasers, for instance, reports thermally affected layers of 10–50 µm for Er:YAG, ten to fifty times its optical depth. How much deeper depends on pulse length, which is the subject of the next section.
Time: confining the heat
Chapter 2 showed that heat needs time to move. A layer that has absorbed light cools by conducting heat into its surroundings, and the time it takes is roughly its thickness squared divided by four times the diffusivity: τ ≈ L² ÷ 4α. This is the thermal relaxation time.
For the 16 µm layer that absorbs CO₂ light, τ ≈ (0.016 mm)² ÷ (4 × 0.14 mm²/s) ≈ 0.5 ms. For the 1 µm layer of an Er:YAG laser, about 2 µs. For a layer 0.1 mm thick, the size of a small blood vessel, about 18 ms.
If the energy arrives in a pulse shorter than the relaxation time, the absorbing layer heats and vaporizes before it can pass heat to its neighbors, and little tissue is damaged beneath the crater. This is thermal confinement. If the pulse is longer, heat spreads while it is still arriving, and more tissue is coagulated. Neither is right in general: confinement gives precision, while spreading gives hemostasis.
Pulse length also sets peak power. One joule delivered in 300 µs is a peak of about 3.3 kW; the same joule over 50 ms is 20 W. At very high peak power, especially in liquid, the absorbed energy boils water so fast that the vapor expands explosively and generates pressure waves. The effect is then partly mechanical as well as thermal, and Chapter 12 shows how lithotripsy lasers use it to break stones.
- Tissue absorbs light through chromophores, mainly water and hemoglobin, and scatters it off everything else.
- Intensity falls as e^(−µaz); water's absorption spans nearly eight orders of magnitude across surgical wavelengths, from about 1 µm deep for Er:YAG to meters at 532 nm.
- Infrared lasers beyond 1.4 µm are set by water, the 532 nm line by hemoglobin, and the 980 and 1,064 nm lines by scattering, which makes them coagulate deeply.
- Pulses shorter than the thermal relaxation time confine heat and give precision; longer pulses spread heat and give hemostasis.
Six ways to deliver energy.
+ The questionIf almost every energy ends as heat in tissue, why does it matter what carries it there?
One frequency axis, two kinds of wave
The previous chapters met each carrier separately. Laid out on one frequency axis, they cover more than ten decades. Ultrasonic instruments vibrate at 23–55.5 kHz. RF generators run at 300–500 kHz. Focused ultrasound works at 0.7–4 MHz. Microwave ablation uses 915 MHz or 2.45 GHz. Surgical lasers emit infrared and visible light from about 28 THz, for the 10.6 µm of CO₂, to about 564 THz, for the 532 nm of KTP. Pulsed-field systems deliver bursts of microsecond pulses, which are not a carrier at all but occupy the low end of the same range.
The axis carries two kinds of wave. Acoustic carriers are mechanical: matter moving back and forth. Electromagnetic carriers are currents, fields and light: charges and fields moving, with no bulk motion of the tissue. Ultrasonic shears and RF generators sit within a factor of ten of each other in frequency, yet they share nothing in how they heat. Cryoablation sits nowhere on the axis, because it carries no energy in; it takes energy out.
Seven mechanisms
What matters to tissue is not the carrier's frequency but the mechanism by which it deposits energy, and every energy in this guide uses one of seven.
- Joule heating. Current flows through tissue and heats it as J²/σ, most where the current is densest. Monopolar and bipolar electrosurgery, vessel sealing and RF ablation all work this way (Chapter 3).
- Friction and cavitation. A vibrating metal surface heats tissue by friction where they touch, and churns it by cavitation. Ultrasonic shears and aspirators work this way (Chapter 4).
- Photothermal absorption. Light is absorbed by a chromophore in a layer about 1/µa deep, which the wavelength sets. Lasers work this way (Chapter 5).
- Dielectric heating. An alternating electromagnetic field rotates water molecules and drives ions back and forth; both motions dissipate energy as heat throughout a volume, with no conducting path to an electrode. Microwave ablation works this way (Chapter 13).
- Focused acoustic absorption. Sound converges on a small focal volume deep in the body and is absorbed there as heat. Thermal focused ultrasound works this way (Chapter 16).
- Heat extraction. A probe colder than tissue draws heat out, and ice grows outward from it. Cryoablation works this way (Chapter 14).
- Non-thermal injury. Strong electric pulses open pores in cell membranes (irreversible electroporation and pulsed field ablation), or intense acoustic pulses tear cells apart by cavitation (histotripsy). The cells die without being heated much (Chapters 15 and 16).
The first five mechanisms deposit heat, but in five different places: in the tissue where current crowds, at the face of a blade, in a layer at the surface, in a volume around an antenna, and at a point deep inside. Those places are the answer to the first half of this guide's question. Each surgical task needs heat in a particular geometry: a line for an incision, a band across a clamped vessel, a surface layer for a precise ablation, a sphere several centimeters across for a tumor, a point behind intact skin. No single carrier can produce all of those geometries.
The seventh mechanism completes that answer. Heat that kills cells also destroys the collagen framework of vessels, bile ducts and nerves. For a tumor wrapped around a major vessel, or for cardiac tissue next to the esophagus, that is exactly the wrong property. The non-thermal energies exist because sometimes the task is to kill cells while leaving their scaffold intact.
What the carrier decides for the device
The carrier also decides almost everything about the device that delivers it. An engineer or founder choosing an energy is choosing a whole set of consequences at once.
Whether current flows through the patient. RF energies need a complete circuit, so they need either a return pad or a second electrode, and they bring every stray-current hazard of Part VII. Ultrasonic, laser and microwave energies need no circuit through the patient, which removes those hazards and brings others.
What the instrument must be. RF needs electrodes and insulation rated for kilovolts. Ultrasonic energy needs a waveguide cut to exact half-wavelengths of vibration in titanium. Lasers need optical fibers or, for CO₂, an articulated arm of mirrors. Microwaves need a coaxial cable and a cooled antenna. Cryoablation needs high-pressure gas lines or liquid nitrogen. Pulsed fields need electrodes that can withstand thousands of volts.
What the power electronics must do. An RF generator is an inverter with an isolation transformer. An ultrasonic generator is a resonant driver that tracks a mechanical resonance. A laser needs a pump source and cooling. A microwave generator is a gigahertz source. A pulsed-field generator stores energy and releases it as kilovolt pulses. A cryoablation console controls gas flow rather than electrical power.
Which standards apply. Electrosurgical equipment is tested to IEC 60601-2-2, lasers to IEC 60601-2-22 and IEC 60825-1, and high-intensity therapeutic ultrasound to IEC 60601-2-62. Ultrasonic surgical systems have an output standard, IEC 61847, but no particular safety standard of their own was found for this guide. Chapter 21 lays out the stack.
The eleven energies at a glance
| Energy | Carrier | Mechanism | Typical task | Chapter |
|---|---|---|---|---|
| Monopolar RF | current, 300–500 kHz | Joule heating at a small electrode | cut, coagulate, dissect planes | 8 |
| Conventional bipolar RF | current between two tips | Joule heating between the tips | coagulate small vessels | 9 |
| Advanced bipolar sealing | current through a clamped vessel | Joule heating under pressure | seal vessels up to 7 mm | 9 |
| Ultrasonic | vibration, 23–55.5 kHz | friction and cavitation at the tip | seal and divide; fragment | 11 |
| Laser | light, 532 nm to 10.6 µm | photothermal absorption | cut, vaporize, coagulate, break stones | 12 |
| RF ablation | current, 460–500 kHz | Joule heating around a needle | destroy tumors in place | 13 |
| Microwave ablation | field, 915 MHz or 2.45 GHz | dielectric heating | destroy tumors in place | 13 |
| Cryoablation | none; cold | heat extraction | destroy tumors in place | 14 |
| IRE and PFA | kilovolt pulses | membrane pores, non-thermal | destroy tissue, spare scaffold | 15 |
| Thermal focused ultrasound | focused sound, 0.7–4 MHz | focal absorption | destroy tissue without incision | 16 |
| Histotripsy | focused sound pulses | inertial cavitation, non-thermal | destroy tissue without incision | 16 |
Two devices can reach the same final temperature in the same tissue and still behave completely differently, because they get there through different geometry, speed and side effects. The carrier decides the geometry and the side effects; the generator's control decides the speed. That is the lens for every instrument chapter that follows.
Before comparing products, place each one on this table: which carrier, which mechanism, where the heat appears. Many apparent disagreements about which device is "better" dissolve once it is clear that two devices put their effect in different places and therefore suit different steps of an operation. Chapter 17 shows this across one colectomy.
- The carriers span more than ten decades of frequency in two kinds of wave, acoustic and electromagnetic; cryoablation has none.
- Every energy acts through one of seven mechanisms; five deposit heat in five different places, one removes heat, and one group kills without heat.
- The geometry of deposition is why surgery needs several energies; the need to spare collagen structures is why some are non-thermal.
- The carrier fixes the instrument, the power electronics, the hazards and the standards a device must meet.
+ Part II · Access
The route to the tissue.
Laparoscopic and robotic surgery add no new energy. They change the conditions under which every energy works: what the surgeon can see and feel, how long and thin the instruments must be, where smoke and heat go, and who, or what, stands between the surgeon's foot and the generator. This short part sets out those conditions before the instrument chapters meet them.
Open, laparoscopic, robotic.
+ The questionWhat changes for an energy device when the surgeon can no longer see or touch the tissue it acts on?
Open surgery: the reference case
In open surgery the surgeon's hand holds the instrument a few centimeters from the tissue. The whole instrument is in view, the tissue can be felt, smoke drifts away into the room, and a burn in the wrong place is usually seen when it happens. Energy devices were designed for these conditions first. The generator that made electrosurgery routine was first used in open neurosurgery: Harvey Cushing operated with William Bovie's generator in Boston on 1 October 1926.
Almost everything in open surgery provides feedback the surgeon does not have to think about. The color of the tissue shows coagulation. The resistance to the instrument shows cutting. The smell and sound of the tissue show when it is drying and charring. Minimally invasive surgery removes most of that feedback, and energy devices have had to replace it.
Laparoscopy: working through a keyhole
In laparoscopic surgery the abdomen is inflated with carbon dioxide at 12–15 mmHg to lift the wall away from the organs, and instruments enter through cannulas 5–12 mm in diameter. A camera on a rigid telescope shows the field on a monitor.
Each of those facts changes how energy behaves.
The view is partial. The camera shows the working ends of the instruments and a few centimeters of their shafts. The rest of each shaft lies inside the abdomen out of view and within reach of bowel. If energy leaves the shaft there, through damaged insulation or capacitive coupling, nobody sees it. Chapter 18 is about exactly that.
The instruments are long and thin. A 5 mm instrument must carry a conductor, its insulation, a jaw mechanism and often a cutting blade. The insulation is thin and rubs against cannulas, it is reprocessed repeatedly if the instrument is reusable, and a long insulated conductor inside a metal cannula forms a capacitor.
The space is small and closed. Smoke from a few seconds of cutting fills the gas volume and obscures the camera, so it has to be evacuated while the pressure is maintained. Heat has nowhere to go but into the tissue; there is no room air to cool a hot jaw between activations, and a jaw that has just sealed a vessel can touch bowel on its way to the next bite.
Motion is reversed. Each instrument pivots at the abdominal wall, so the tip moves opposite to the hand, and the surgeon's sense of force through a long shaft and a sealing valve is poor. Judging how hard a jaw is squeezing, or when a seal is complete, by feel alone becomes unreliable.
Robotic surgery: a controller in the loop
A surgical robot restores some of what laparoscopy removed. The surgeon sits at a console with a three-dimensional view, instruments have wrists that bend inside the body, and the system scales motion and filters tremor. The instruments still enter through ports in an insufflated abdomen, so every condition above still applies.
The robot also adds something. In open and laparoscopic surgery, the surgeon's pedal or hand switch activates the generator directly. In robotic surgery, activation passes through the robot's own controller, which decides whether the command reaches the generator. On some systems the generator is integrated into the robot: Intuitive, for example, markets its vessel sealers and its SynchroSeal instrument as powered by the integrated E-200 generator. Energy delivery then depends on two control systems working together, and the risk analysis must cover both.
Robotic instruments are reused a set number of times and have complex wristed shafts, and they bring their own insulation problem. One prospective study found insulation failures in 32 % of robotic instruments against 13 % of laparoscopic ones, rising to 80 % against 36 % after ten uses. Chapter 18 returns to these numbers.
What the access route asks of energy devices
Taken together, minimally invasive access asks four things of an energy device that open surgery did not.
Do more than one job per instrument. Every instrument exchange takes time and risks losing the view, so instruments that grasp, seal and cut in one device became central to laparoscopy. Advanced bipolar sealers with built-in blades, ultrasonic shears and hybrid instruments all answer this need.
Decide the end point. When the surgeon cannot see blanching or feel the tissue change, the generator must decide when a seal is finished. Closed-loop control, in which the generator measures the tissue and stops by itself, is the answer, and Chapters 9 and 10 describe how it works.
Keep energy inside the instrument. Insulation, shielding and monitoring must stop current leaving the shaft outside the camera's view.
Manage what the energy leaves behind. Smoke must be evacuated without losing pressure, and heat retained in jaws and blades must be managed, for instance by thermal shields on the outer surfaces of the jaws, which at least one current hybrid instrument now includes.
A robot moves instruments; it does not by itself decide how much energy to deliver. Energy delivery on robotic systems is still commanded by the surgeon and controlled by a generator, and the same physics, hazards and tests apply as in laparoscopy. What the robot adds is another controller and another set of interfaces that must be verified.
For a device intended for minimally invasive use, the access route belongs in the design inputs from the start: shaft length and diameter, insulation material and thickness, compatibility with metal and hybrid cannulas, smoke management, and, for robotic use, the interface to the robot's controller and its activation path. FDA's electrosurgical guidance asks for capacitive-coupling testing with a conductive cannula for monopolar instruments used in minimally invasive surgery, for exactly these reasons.
- Minimally invasive access adds no energy but changes the conditions: a partial view, long thin instruments, a small closed space and reversed motion.
- Most of each instrument shaft is out of the camera's view and within reach of bowel.
- Robotic surgery restores dexterity and depth perception but places the robot's controller between the surgeon's pedal and the generator.
- The access route pushes energy devices toward multifunction instruments, closed-loop end points, containment of stray energy and management of smoke and residual heat.
+ Part III · Current through the patient
Electrosurgery.
The oldest surgical energy is still the most used. These three chapters follow radiofrequency current from the tip of a monopolar pencil, through the jaws of a vessel sealer, to the generator that must drive both. The physics is Chapter 3's: heat appears where current is densest. The engineering is how to make that happen only where the surgeon intends.
Monopolar RF.
+ The questionIf current must cross the whole body to complete its circuit, how does it heat only the point the surgeon touches?
The circuit
A monopolar electrosurgical system is a simple circuit with one unusual component. A generator drives high-frequency current out through a lead to the active electrode, the pencil, hook or scissors in the surgeon's hand. The current enters the patient at the electrode's tip, spreads through the body, and leaves through a large return electrode, the pad on the patient's thigh or back, which leads it back to the generator. The unusual component is the patient, a conductor of irregular shape and varying conductivity lying in the middle of the circuit.
The circuit works because of the geometry of Chapter 3. The same current flows through the tip and the pad. At the tip it is squeezed into a fraction of a square millimeter; at the pad it spreads over tens of square centimeters. Current density differs between them by a factor of thousands, and heating by that factor squared. Tissue at the tip boils in milliseconds while skin under the pad warms by a few degrees.
The early history of the technique is a history of learning that lesson. Bovie's 1926 generator relied on a spark gap for coagulation, and for decades afterwards generator outputs were referenced to earth. With an earth-referenced output, current could return to the generator through any earthed contact, such as an ECG electrode or a metal part of the table, and if that contact was small, it burned. Generators with isolated outputs, which float electrically and return current only through their own return lead, arrived in the late 1960s and early 1970s; a Valleylab patent filed in 1971 describes an all-solid-state generator with isolated outputs "to prevent patient burns caused by alternate return paths". Almost all generators now have isolated outputs.
At the tip: from contact to arcs
What the current does at the tip depends mainly on voltage. Below about 200 V peak, current flows by direct contact between the electrode and moist tissue. The tissue heats, its water boils away gradually, and it dries into a coagulum: this is desiccation, or soft coagulation, and it produces no sparks.
Above about 200 V peak, something different happens. The first burst of heating makes a thin layer of steam between the electrode and the tissue. Steam does not conduct, but at these voltages the field across the thin layer is strong enough to ionize it, and current crosses the gap as tiny arcs. Each arc concentrates its energy into a spot a few micrometers across, so the cells under it vaporize and burst. The electrode, riding on its own steam envelope, moves through tissue in a line of bursting cells without ever touching it: it cuts without being sharp. The European endoscopy society's technical guideline gives the practical thresholds: below 200 V peak, voltage suffices for soft coagulation but not for cutting; around 300 V peak gives a pure cut.
At higher voltages still, kilovolts, interrupted bursts of current jump across an air gap of a millimeter or more to the tissue surface. The arcs spread over the surface, dry and char it, and stop oozing from a broad area. This is fulguration, or spray coagulation, and it needs no contact at all.
The waveform decides the effect
A generator produces these different effects by changing the shape of its output rather than simply its power. For cutting it delivers a continuous sine wave at a few hundred volts. For coagulation it delivers the same carrier in short bursts, switched on for only a small fraction of each cycle, at much higher peak voltage. The fraction of time the output is on is the duty cycle, and the ratio of peak voltage to RMS voltage is the crest factor.
For a sine wave switched on for a fraction d of the time, the crest factor is roughly √(2 ÷ d). A continuous sine has a crest factor of 1.4. At a duty cycle of 6 %, the crest factor is about 5.8, so to deliver the same average power, the peak voltage must be about four times higher. That is why coag waveforms reach kilovolts.
A current generator's specification sheet shows the pattern clearly. For the Valleylab FT10, the manufacturer lists pure cut at 100 % duty cycle, crest factor 1.6 and 1,287 V maximum peak; a blend mode at 50 % duty, crest factor 2.2 and 2,178 V; a hemostatic cut at 25 %, 3.2 and 2,783 V; fulguration at 6.25 %, 5.4 and 3,448 V; and spray at 4.76 %, 6.2 and 3,932 V.
The high peak voltage of the coag waveforms is what makes them arc over a gap, and it is also what makes them dangerous in the ways Part VII describes. Higher voltage breaks through damaged insulation more easily and couples more current through stray capacitance. The same power at a low crest factor cuts; at a high crest factor it coagulates and fulgurates. The effect on tissue follows the waveform far more than the number on the power dial.
Manufacturer tables usually give peak voltage, measured from zero to the top of the wave. Clinical reviews often give peak-to-peak, from the bottom to the top, which is twice as large for a symmetrical wave. A "cut at 2,000 V" and a "cut at 1,000 V" may describe the same waveform. When comparing numbers, find out which is meant.
The return pad
The return pad works only while its area stays large. If part of it peels away, the same current crowds into the remaining contact, and because heating rises with the square of current density, the skin under the edge that still touches heats fastest. A pad that has lost two thirds of its contact heats roughly nine times more per square centimeter.
Two engineering responses followed. The first is a test. The AAMI HF18 standard required that a return electrode carrying 700 mA for 60 seconds must not raise the temperature of the skin beneath it by more than 6 °C, and IEC 60601-2-2 now specifies an equivalent test with currents set by patient weight. A patent citing the standards puts the threshold for tissue necrosis at about 100 mA per square centimeter; 700 mA spread over a pad of about 130 cm² is about 5 mA per square centimeter, twenty times below it.
The second is a monitor. A split pad has two halves, and the generator passes a small interrogating current from one half to the other through the skin. If the pad starts to lift, the impedance between the halves rises. Valleylab filed a patent on the idea in 1981, granted in 1983, using a 140 kHz, 2 mA monitoring signal and a window between a fixed lower limit of 20 Ω and an adaptive upper limit at 120 % of the starting value. Current generators do the same. The manufacturer's specification for the FT10 accepts 5–135 Ω between the halves, and service manuals for earlier Valleylab generators describe an alarm when the impedance rises more than 40 % above its starting value. When the monitor alarms, the generator stops.
The monitor protects only if the pad is used as designed. Pads come in sizes for patient weight and must never be cut down for a child: cutting reduces the area and can defeat the split-pad monitor. In a published knowledge test of surgical society leaders, 10 % believed pads could be cut for pediatric use. Guidelines ask for placement over well-perfused muscle, as close to the operative site as practical, so the current path through the body is short.
Blocking capacitors
One more component sits in every monopolar output: a capacitor in series with each lead. Chapter 3 noted that an arc conducts slightly better in one direction than the other, so it partly rectifies the current and creates a small direct-current component. A series capacitor passes the high-frequency current freely but blocks direct and low-frequency current, which could otherwise stimulate nerves and muscles. A patent on the subject notes that the charge an arc builds up on such a capacitor can itself discharge at low frequency through tissue when the arc stops, so the capacitor's size is a design decision, not an afterthought.
A monopolar generator's datasheet answers most safety questions if it is read with this chapter in mind. Check the peak voltage and crest factor of each mode, because they govern arcing and coupling. Check the rated load, because the waveform is specified at that load and nowhere else. And check the contact-monitor window, because it decides how much pad lift the generator tolerates before it stops.
- Monopolar current enters through a small active electrode and leaves through a large return pad; only the difference in area confines the heat to the tip.
- Below about 200 V peak, contact current desiccates; above it, current arcs across a steam envelope and vaporizes cells, so the electrode cuts without being sharp.
- Lower duty cycles need higher crest factors and peak voltages; the waveform, not the power setting, decides cut, blend, fulguration or spray.
- Split return pads with contact monitoring, isolated outputs and blocking capacitors keep current from heating anything but the tip.
Bipolar and vessel sealing.
+ The questionA sealer cannot see inside its own jaws. How does it know when a seal is complete?
Bipolar: the circuit in the instrument
A bipolar instrument carries both electrodes in its tips, usually the two blades of a forceps. Current flows from one tip to the other through only the tissue held between them, so no return pad is needed and almost no current wanders through the rest of the patient. The voltages are low: the Valleylab FT10 lists its bipolar modes at 70 W into a 100 Ω rated load, with maximum peaks of 184–530 V depending on the mode, a fraction of the kilovolt peaks of monopolar coag.
Conventional bipolar forceps coagulate small vessels and bleeding points precisely. Their weakness is that the surgeon decides how long to apply energy. Too short and the vessel is not closed; too long and the tissue dries, chars and sticks to the tips, and when the forceps open the vessel may tear. For vessels larger than a few millimeters, conventional bipolar coagulation was never reliable enough to replace a tie.
Advanced bipolar: pressure, current and a closed loop
The advanced bipolar vessel sealer changed that. The first, Valleylab's LigaSure, was cleared by FDA on 28 August 1998 under 510(k) K981916. Its later 510(k) summary describes the mechanism in regulatory language: collagen and elastin in the tissue are re-formed by heat and pressure to fuse the vessel walls into a permanent seal, while a microprocessor monitors the tissue, ends energy delivery and allows the seal to cool before signaling that it is complete. It is indicated for vessels up to and including 7 mm in diameter, a limit many advanced bipolar sealers share; some robotic sealers are limited to 5 mm.
Three things distinguish a sealer from a bipolar forceps. The jaws apply high, controlled pressure, squeezing the vessel flat so that its two walls touch along their whole width and blood is pushed out of the jaw. The generator delivers high current at low voltage: the FT10's sealing mode is rated at 20 Ω, up to 350 W, a maximum of 5.5 A and a peak of at most 244 V. Into wet, clamped tissue the voltage stays far lower, so it heats without arcing. And the generator runs a closed loop, measuring the tissue continuously and deciding for itself when to stop.
The seal itself is the collagen fusion of Chapter 1. Heated to the point where its helices unwind, and held under pressure while it cools, the collagen and elastin of the two opposed walls entangle into a single translucent band. Heat that escapes sideways from the jaw is the thermal spread. For one manufacturer's current sealers, a study written by its staff reports in vivo spread of about 1.3–2.1 mm and seal times of about 2–4 seconds.
Impedance tells the generator what is happening
Inside the jaw, the generator has no camera and no thermometer in the tissue. What it has is the voltage and current at its own output, and from those it computes the tissue's electrical impedance, many thousands of times a second. The manufacturer of the FT10 states that its sealing algorithm samples impedance 434,000 times a second.
Impedance tells a surprisingly complete story. As the tissue warms, its conductivity rises by about 2 % per degree, so the impedance first falls. As the tissue approaches 100 °C, water begins to boil off, the remaining tissue conducts worse and worse, and the impedance turns upward and then climbs steeply. When the climb shows that the water has largely gone, the collagen has done what it can, and further energy would only char it. The generator stops, waits while the seal cools in the closed jaws, and sounds a tone.
Different devices implement the same idea differently. Some regulate on impedance directly. EnSeal, from Ethicon, uses a jaw material whose conductivity falls sharply as it warms, so each part of the jaw limits its own temperature. Olympus's PK system pulses its bipolar energy. The physics they manage is the same: deliver enough energy to fuse the collagen, stop before the tissue dries into char.
A sealer never measures the seal. It measures impedance and infers the seal from the shape of the impedance curve, using an algorithm tuned on bench and animal tests. That is why the strength of a seal must be demonstrated by testing, not by reading the generator's display, and why a seal made outside the conditions the algorithm was tuned for, a larger vessel or unusual tissue, may not be as strong as the tone suggests.
How strong is a seal?
The bench test for a seal is the burst pressure. A sealed vessel is filled with liquid and the pressure raised until the seal fails, and the pressure at failure is recorded. Normal systolic blood pressure is about 120 mmHg. A widely used acceptance level is 360 mmHg, three times systolic; the manufacturer of LigaSure uses it as its lower specification limit, and published studies often compare against it. It is an industry convention, not a regulatory requirement: FDA's guidance for bipolar vessel sealers sets out how to test burst pressure but gives no pass value.
Measured burst pressures are usually far above that line when a device is used within its indication. In one independent bench comparison on arteries of 5.1–7 mm, seals from five devices held between about 570 and 1,740 mmHg; the lowest was an ultrasonic device indicated for vessels only up to 5 mm. The same study tested one bipolar sealer on arteries of 7.1–9 mm, beyond its 7 mm indication, and its burst pressure fell from 1,165 to 530 mmHg. The indicated vessel size is not a formality; it is where the physics stops being reliable.
FDA's guidance for bipolar vessel sealers, issued in 2016, describes the evidence expected before such a device reaches the market. Burst pressure is tested for each mode against the predicate device, across the vessel sizes and types claimed. Thermal spread is measured by histology. A chronic animal study of at least three weeks, in at least five animals and under good laboratory practice, shows that seals stay closed as the tissue heals. And the indication must state the maximum vessel size, measured in its rounded, perfused state in a subject with normal blood pressure.
Burst pressure depends on the vessel's size, type, collagen content and whether it was tested fresh, and on how the pressure was applied. Numbers from different studies, or from a manufacturer's own study against a competitor, are rarely comparable. Look for the same vessels, the same method and an independent laboratory before drawing conclusions.
Designing or evaluating a sealer comes down to three controlled variables and one inferred outcome. Jaw pressure, energy delivery and end-point detection are designed and verified; seal strength is inferred and must be demonstrated. A verification plan that tests each variable at its limits, the lowest jaw force, the largest indicated vessel, the thickest tissue, is testing the inference as well as the hardware.
- Bipolar instruments pass current only through the tissue between their tips, at low voltage and with no return pad.
- Advanced sealers add high jaw pressure, high current at low voltage and a closed loop that ends energy delivery by itself; many are indicated for vessels up to 7 mm.
- The generator infers the seal from impedance, which falls as tissue warms and climbs steeply as it dries.
- Burst pressure is the bench test; 360 mmHg is an industry convention, not an FDA requirement, and strength falls sharply beyond the indicated vessel size.
The RF generator.
+ The questionHow can one box seal a vessel at 20 Ω and sustain an arc into a load of two kilohms through the same output?
The load problem
An electrosurgical generator drives a load that no power-supply designer would choose. Tissue impedance depends on the tissue, the electrode, the contact area and, above all, on what the energy is doing to the tissue at that instant. A vessel clamped in a sealer's jaws, wet and well compressed, looks like about 20 Ω. Tissue under a cutting electrode is about 300 Ω. A coagulation arc across a gap, or tissue that has dried, can be 2 kΩ or more. When an arc starts or stops, the impedance can change by a large factor within microseconds.
Manufacturers therefore specify each mode at a rated load, the impedance at which its power and waveform are defined. For the Valleylab FT10 those loads are 20 Ω for sealing, 100 Ω for bipolar and soft coagulation, 300 Ω for monopolar cut and 500 Ω for fulguration and spray, and manufacturers plot output power against load across 0–2,000 Ω. A single generator must cover that whole range with every mode it offers.
Using P = V²/R and I = V/R: - Sealing, 350 W into 20 Ω: V = √(350 × 20) ≈ 84 V RMS, I ≈ 4.2 A. - Cut, 300 W into 300 Ω: V = 300 V RMS, I = 1.0 A. - Coag, 120 W into 500 Ω: V ≈ 245 V RMS, I ≈ 0.49 A. At a crest factor of 6, the peak is about 1.47 kV. - Spray, 80 W into 2,000 Ω: V = 400 V RMS, I = 0.2 A. At a crest factor of 8, the peak is about 3.2 kV.
The coag and spray figures are illustrative assumptions, not a particular generator's specification.
The example makes the difficulty plain. The output must deliver more than four amperes in one mode and more than three kilovolts peak in another. The power levels differ by a factor of only about four; the load resistances differ by a factor of a hundred. It is the load range, far more than the power, that makes an electrosurgical output stage hard to design.
The power chain
Published patents describe how a generator turns mains power into that output in stages. A Covidien patent granted in 2017 describes the core of it, research designs follow the same structure, and the list below combines them with earlier designs.
- The mains input filters and rectifies the incoming supply.
- A DC supply, isolated from the mains, produces a steady internal voltage.
- A DC-DC converter, typically a buck converter, sets the amplitude of the output by adjusting that voltage.
- An inverter, often a full H-bridge of power transistors, switches the DC at the carrier frequency, 300–500 kHz, and creates the burst patterns of the coag modes by switching on and off.
- An output network filters the switched waveform into a sine, sometimes using a resonant circuit.
- An isolation transformer passes the output across the barrier between the internal circuits and the patient and sets the voltage ratio.
- Blocking capacitors in each output lead stop direct and low-frequency current, as Chapter 8 described.
Splitting the job this way lets each stage do one thing well. The converter controls amplitude, which is what closed-loop control needs to adjust quickly. The inverter controls frequency and timing, and can stay at a fixed frequency where the output network is efficient. The transformer and the internal supply voltage together bound the voltage and current the stage can reach, and choosing them to span both ends of the load range is the central design trade.
The earliest solid-state generators used the same ideas in simpler form. Valleylab's 1971 patent describes coagulation produced near the resonant frequency of an output circuit, at about 400 kHz and 4,000 V open circuit, and cutting produced off resonance at lower peak voltage.
Holding the output: three limits
A generator cannot deliver its set power at every load, because the power stage has a maximum current and a maximum voltage. Into a very low impedance, the current limit is reached first, and power rises in proportion to the load as P = I²R. Into a very high impedance, the voltage limit is reached first, and power falls as P = V²/R. Only between the two can the generator hold the power the surgeon set. Every electrosurgical mode therefore has three regions: current-limited, constant power and voltage-limited.
The closed loop works to hold the output in whatever region the tissue puts it. It measures voltage and current at the output, computes power and impedance, and adjusts the converter, often thousands or hundreds of thousands of times a second; one manufacturer states 434,000 impedance samples a second for its sealing mode. Holding power steady is harder than it sounds, because an arc can change the load faster than a slow loop can react, and control methods for exactly this problem are an active research topic.
IEC 60601-2-2 and FDA guidance both ask for the resulting curves. FDA's electrosurgical guidance asks for graphs of power output at maximum and at half of maximum setting over the range of expected loads, derived from measured data rather than theory, together with the output waveform of each mode at its rated load: amplitude, frequency, duty cycle, crest factor and maximum voltage.
Duty cycle and high current
A generator also has thermal limits of its own. A service manual for an earlier Valleylab generator rates maximum pure cut into 300 Ω for 10 seconds on and 30 seconds off, for one hour. IEC 60601-2-2 adds rules for outputs that deliver a lot of current for a long time. It defines a heating factor, current squared multiplied by time, and treats any output able to exceed 30 A²s in any 60 seconds as a high current mode, which brings stricter requirements for the return electrode. Its 2023 amendment added a requirement to assess duty cycles above 45 % in the risk analysis.
For each mode, find: - the rated load, the maximum power and where the power-versus-load curve leaves its flat region; - the maximum peak voltage and crest factor, which govern arcing, coupling and insulation stress; - the carrier frequency and burst repetition rate; - the declared high-frequency leakage current; - the contact-monitor window for the return pad; - any duty-cycle limit.
Then compare the rated load with the impedance of the tissue the device will actually meet. A mode rated at 300 Ω and used mostly on tissue at 1,000 Ω may run in its voltage-limited region, at less power than its setting; the power-versus-load curve shows whether it does.
The number on the dial is the power the generator delivers at the rated load and across its constant-power band. Outside that band it delivers less, sometimes much less. Two generators set to the same power can deliver different power to the same tissue, which is one reason clinical results do not always transfer between generators.
- A generator must drive loads from about 20 Ω to 2 kΩ or more; the load range, more than the power, makes the output stage hard to design.
- The power chain runs from mains input through a DC supply, an amplitude converter, a high-frequency inverter and an output network to an isolation transformer and blocking capacitors.
- Every mode has current-limited, constant-power and voltage-limited regions; the closed loop holds the output within them as tissue changes.
- Datasheets and 510(k) submissions declare power-versus-load curves at maximum and half setting, waveforms at rated load, and limits on high-current duty.
+ Part IV · Sound and light
Energy without current.
Ultrasonic instruments and lasers deliver energy with no current through the patient. One vibrates a titanium blade at a mechanical resonance; the other turns electricity into light of one wavelength. These two chapters follow each from the power supply to the tissue, and show how their physics sets both what they do well and the hazards they bring.
Ultrasonic and hybrid instruments.
+ The questionHow does a blade that is never sharp cut tissue and seal vessels without passing any current through the patient?
From voltage to motion
Certain crystals and ceramics change shape when a voltage is applied across them and produce a voltage when they are squeezed. This is the piezoelectric effect, and it is how an ultrasonic instrument turns electrical power into vibration. The movement of a single piezoelectric ring is tiny, well under a nanometer per volt, so instruments stack several rings and drive them at their mechanical resonance, where small forces build up large motion.
The standard arrangement, called a Langevin stack, clamps a few piezoelectric rings between a heavy back mass and a front mass with a bolt through the middle. The bolt keeps the rings in compression, because ceramic cracks easily under tension. Ethicon's original Harmonic transducer used four piezoelectric elements held between two aluminum end bells. The front mass tapers into a horn, which amplifies the motion toward its narrow end.
A waveguide cut to the wavelength
From the horn, the vibration travels down a slender titanium-alloy waveguide to the blade. Vibration in a rod is a sound wave, and at the operating frequency the rod carries a standing wave: points that never move, called nodes, alternate with points of maximum motion, called antinodes, half a wavelength apart. Patents describe waveguides whose length is a whole number of half-wavelengths, with the blade tip at an antinode for maximum motion and the supports that hold the waveguide inside its sheath at nodes, where there is no motion to lose.
The half-wavelength is easy to estimate, with one subtlety. A slender rod vibrates in an extensional mode whose speed is set by the material's stiffness and density, about 5,000–5,100 m/s for titanium and its alloys, which is lower than the bulk speed of sound quoted in tables. At 55.5 kHz, the operating frequency of Ethicon's Harmonic instruments, half a wavelength is about 5,090 ÷ 55,500 ÷ 2 ≈ 46 mm. At 47 kHz, the frequency Olympus lists for its current ultrasonic generator, it is about 54 mm. Using the bulk speed of about 6,100 m/s would overestimate both by about 20 %.
At the blade the motion is 50–100 µm, usually quoted as the full stroke. One recent study reports 100 µm at the highest power level of a current generator and 70 µm at its middle level. If 100 µm is the full stroke, as Chapter 4 assumed, that is a tip speed of about 17 m/s and an acceleration of more than 600,000 times gravity.
The transducer as a circuit
Electrically, a piezoelectric stack looks like a capacitor in parallel with a resonant circuit. The capacitor, C0, is the ceramic's own capacitance. The resonant branch has an inductance that stands for the moving mass, a capacitance that stands for the stiffness, and a resistance that stands for the mechanical losses, including the tissue pressed against the blade. This is the Butterworth–Van Dyke model, and ultrasonic generator patents are written in its terms.
The model explains how the generator works. The current in the resonant branch, the "motional" current, is proportional to the velocity of the blade. The generator therefore regulates that current to hold the blade's motion constant, compensating for the current that flows through C0 and does no mechanical work. It also tracks the resonance, because tissue load and temperature move it. The original Harmonic generator used a phase-locked loop that adjusted its frequency up or down to stay at resonance; later patents describe tracking the frequency at which the phase between voltage and current crosses zero. Ethicon's generator manual lists its ultrasonic output as 150 V RMS maximum and 35 W continuous.
How it cuts and seals
Pressed against tissue, the blade heats it by friction and by internal losses, as Chapter 4 described. Proteins unfold into a sticky coagulum that seals small vessels, and with enough pressure the tissue parts along the blade. Sealing depends on compression, heat and time, the same variables as bipolar sealing. Standard ultrasonic shears are indicated for vessels up to 5 mm. In 2013, Ethicon's Harmonic ACE+7 was cleared for vessels up to 7 mm, the first ultrasonic device so indicated according to the company, using a mode that modulates energy delivery during the seal.
Because no current flows through the patient, ultrasonic instruments avoid the stray-current hazards of Chapter 18, which matters most near structures such as bowel. They carry a different hazard: heat retained in the blade.
Heat left in the blade
Ultrasonic cutting is often described as a low-temperature technique, and textbooks give tissue temperatures of about 80 °C at the cut. The blade is another matter. In one bench study, reported as a conference abstract, the temperature measured at ultrasonic devices rose by an average of 172 ± 63 °C, against 81 °C for monopolar and 46 °C for bipolar devices; the others fell to within 20 °C of baseline within five seconds, while the ultrasonic devices stayed hot for the full 20 seconds observed. In another study, a blade fired with no tissue in its jaws exceeded 400 °C, and its tissue pad melted 13.2 seconds after activation.
Both statements are true; they describe different things. The tissue at the cut stays moderate because its water holds the temperature near 100 °C and the tissue is removed. The metal has no water and a small heat capacity, and it keeps its heat after the vibration stops. A hot blade that touches bowel on its way to the next bite causes a burn as surely as a current would, and firing an ultrasonic blade without tissue in the jaws makes it hotter still.
The absence of current through the patient removes one class of hazard and leaves another. For ultrasonic instruments, the thermal hazard sits in the blade after activation, not in the tissue during it. Instructions for use, training and jaw design all address it, and so should any comparison of devices.
Hybrid instruments
A hybrid instrument combines ultrasonic and bipolar energy in one jaw. Olympus launched THUNDERBEAT in March 2012, after FDA clearance under 510(k) K111202; the company describes it as delivering frictional heat from ultrasonic vibration and bipolar heat from current simultaneously. Bipolar current heats the tissue from within, while friction at the probe heats it from the surface and divides it, so one bite can seal and cut.
The current version illustrates how such devices evolve. FDA cleared THUNDERBEAT II under K252150 on 7 October 2025. Its summary lists ultrasonic output at 47 kHz and bipolar output at 380 kHz and describes three modes: Seal & Cut with both energies, Seal with bipolar only, and an ultrasonic-only mode indicated for vessels up to 3 mm, against 7 mm for the sealing modes. The generator, the USG-410, had been cleared separately in 2021. The new transducer is described as cordless, which here means that the cable has been moved to the base of the handle, not that the device runs on a battery. Olympus also describes a thermal shield on the jaw that slows heat transfer to its outer surface.
Aspirators
A second family of ultrasonic instruments does not seal at all. Ultrasonic aspirators vibrate a hollow tip at 23 or 36 kHz, fragment tissue just in front of it, mainly by cavitation together with direct mechanical impact, and irrigate and suction away the fragments. Water-rich, weakly cohesive tissue such as liver parenchyma or tumor breaks up, while collagen-rich vessels, ducts and nerves survive to be clipped or sealed. The selectivity comes from the tissue's mechanics, not from heat.
- A Langevin stack of piezoelectric rings drives a titanium waveguide at resonance; the waveguide is a whole number of half-wavelengths, about 46 mm at 55.5 kHz, with the blade tip at an antinode.
- The generator regulates the motional current, which sets blade velocity, and tracks the resonance as load and temperature move it.
- Ultrasonic shears seal vessels up to 5 mm, or 7 mm for newer designs, with no current through the patient, but the blade retains heat after activation.
- Hybrid instruments combine bipolar and ultrasonic energy in one jaw; aspirators fragment tissue mechanically, largely by cavitation, while sparing vessels.
Surgical lasers.
+ The questionChapter 5 showed that the wavelength decides where light is absorbed. What does it take to make light of one wavelength, and how does that choice shape a laser's whole design?
How a laser makes light
Atoms and molecules hold energy in discrete levels, and they absorb or emit light when they move between them. Normally most are in their lowest level, so light passing through a material is more likely to be absorbed than to trigger emission. A laser reverses that balance. A pump, which may be a flashlamp, a diode laser or an electrical discharge, lifts atoms of a gain medium into an excited state faster than they can fall back, until more are in the upper laser level than in the level below it. This is a population inversion.
In that state, a photon of exactly the right energy passing an excited atom can trigger it to emit a second photon identical to the first: the same wavelength, the same phase and the same direction. This is stimulated emission, and each triggering event turns one photon into two. Mirrors at either end of the gain medium send the light back and forth through it, so it is amplified on every pass. One mirror lets a small fraction through, and that fraction is the beam. Lasing begins when the gain on each pass exceeds the losses.
How the pump is made largely sets how much of the mains power ends up as light. A holmium laser pumped by flashlamps converts less than 1–2 % of its electrical input into light, because the lamp's broad spectrum overlaps the holmium absorption only slightly; the rest is heat that must be removed by water cooling. A thulium fiber laser pumped by diodes whose output matches thulium's absorption converts about 12 % and can be air-cooled. Carbon dioxide lasers, pumped by an electrical discharge through the gas, reach 10–20 %.
The difference shows on the nameplate. The manufacturer of one 120 W holmium system lists a single-phase supply of 200–240 V at up to 46 A and a weight of about 250 kg; a 60 W thulium fiber laser from another manufacturer runs from 100–240 V at 1,200 VA and weighs about 40 kg. Dividing optical output by electrical input gives about 1.1–1.3 % for the first and at least 5 % for the second, consistent with the published efficiencies.
Lasers and their jobs
Chapter 5's absorption curves decide what each laser is for.
The CO₂ laser, at 10.6 µm, is absorbed within about 16 µm of tissue, so it vaporizes a thin layer precisely with little coagulation beneath. It is used for cutting and vaporizing soft tissue and in airway surgery, where precision near delicate structures matters. The Ho:YAG laser, at 2.1 µm, and the thulium fiber laser, at 1.94 µm, are absorbed within about 0.5 mm and 0.1 mm respectively, so they cut and coagulate together, thulium in a shallower layer; both work well under water, which is why they are used to treat stones and to enucleate an enlarged prostate. The 1,470 nm diode laser is also water-absorbed within about half a millimeter and is used, for example, to close varicose veins from inside with a radial fiber. The 980 nm diode and the Nd:YAG laser at 1,064 nm are weakly absorbed and scattered over millimeters, so they coagulate deeply. The 532 nm green laser, made with a KTP or LBO crystal, is absorbed by hemoglobin and passes through water, which suits vaporization of a blood-rich prostate under irrigation.
Getting the light there
The wavelength also decides how light reaches the tissue. Silica optical fibers carry light from the visible to about 2 µm with little loss, so every laser above except CO₂ can be delivered through a flexible fiber small enough to pass down an endoscope. The core size matters: holmium lasers need fibers of 200 µm core or larger because their beam quality limits how tightly they can be focused into a fiber, while thulium fiber lasers couple into fibers as small as 50–150 µm. Green-laser systems for the prostate use a side-firing fiber with a 750 µm core, which directs the beam sideways at the tissue.
Silica absorbs 10.6 µm light strongly and cannot carry a high-power CO₂ beam. CO₂ lasers are therefore delivered by an articulated arm of mirrors, or through hollow waveguides made for the purpose.
Pulses, bubbles and stones
Chapter 5 showed that pulse length sets how far heat spreads and how high the peak power climbs. Lithotripsy lasers use both. A holmium pulse delivers about 1 J in roughly 300 µs, a peak of about 3.3 kW. A thulium fiber laser works at a peak of about 500 W, so the same joule takes about 2 ms, and it compensates with far higher repetition rates; one current system offers pulse energies from 0.025 to 6 J at up to 2,400 Hz, according to its manufacturer.
Under water, a laser meets an obstacle before it reaches the stone: the water itself absorbs the light. The front of each pulse therefore boils a vapor bubble at the fiber tip, and the light that reaches the stone is the light that passes through that bubble. Since 2017, pulse-shaping modes have exploited this by firing a short, low-energy sub-pulse to open the bubble and then the main pulse through it, so more of the energy reaches the stone. The manufacturer of one such mode claims 50 % less stone movement and a 33 % higher ablation rate.
Pulse settings then decide how a stone breaks. For dusting, a published review gives low pulse energies of 0.2–0.5 J at 50–80 Hz with long pulses, which erode the stone into fine particles that can be washed out. For fragmentation, it gives 0.5–1 J at 5–20 Hz with short pulses, which break the stone into pieces to be removed with a basket. Longer pulses, lower energies and smaller fibers all reduce the recoil that pushes a stone away from the fiber.
A laser's wavelength decides what absorbs it, how deep the energy goes, which fibers can carry it, and, through the pump that makes it, how much mains power it draws and how it must be cooled. Choosing a wavelength is choosing most of the system.
Figures such as "50 % less retropulsion" come from manufacturers' own testing, under conditions they chose. They show that the mechanism works; they are not a measure of clinical benefit in a particular patient or stone type. Independent comparisons, with the same stones, fibers and settings, are the evidence to look for.
- A laser pumps a gain medium into population inversion and amplifies stimulated emission between mirrors; the pump sets efficiency, from under 2 % for flashlamp-pumped holmium to about 12 % for thulium fiber.
- The wavelength decides the job: CO₂ for precise vaporization, holmium and thulium for cutting under water and stones, 980 nm diode and Nd:YAG for deep coagulation, 1,470 nm diode for vein closure, 532 nm for blood-rich tissue.
- Silica fibers carry every surgical wavelength up to about 2 µm; CO₂ needs mirrors or hollow waveguides.
- Under water each pulse must first boil a vapor channel; pulse shaping and pulse settings decide how much energy reaches a stone and whether it dusts or fragments.
+ Part V · Destroying tissue in place
Ablation.
Resection removes a tumor; ablation kills it where it lies, through a needle or from outside the body, and leaves the dead tissue for the body to clear. The four chapters of this part cover heating with current and microwaves, freezing, pulsed electric fields and focused sound. Each has a different answer to the same two questions: how large a volume can be killed, and what happens at its edge.
RF and microwave ablation.
+ The questionAn RF needle and a microwave antenna of similar size both heat tumors. Why does the microwave antenna heat faster and hotter, and why does it stall less?
Killing a volume in place
Ablation asks for something different from cutting or sealing. The target is a sphere or an ellipsoid a few centimeters across, a tumor plus a margin of normal tissue around it, and every cell in that volume must be held above about 60 °C long enough to die, while the tissue outside it is spared. The device is usually a needle placed through the skin under ultrasound or CT guidance, so the heat must spread outward from a thin probe into a volume many times its size.
Chapter 2's physics sets the difficulty. Heat conducts slowly, blood carries it away, and large vessels act as sinks. The two heating ablation energies, RF and microwave, take different approaches to the problem, and the difference comes down to where each one deposits its power.
RF ablation: heat in a thin shell
An RF ablation needle is an electrosurgical electrode used differently. The generator, typically operating at 460–500 kHz and delivering up to 200–250 W in current models, passes current from the needle's exposed tip through the tumor to return pads on the patient's skin. The heating follows Chapter 3: current density falls steeply away from the needle, so almost all the power is deposited in a shell a few millimeters thick around the tip. The rest of the zone is heated by conduction from that shell, over minutes.
The approach has a built-in limit. Tissue touching the needle is the hottest, and as it reaches 100 °C it dries and chars. Dry, charred tissue conducts poorly, so the impedance at the electrode rises sharply, the current falls and the generator can no longer deliver power. This is impedance roll-off, and when it happens the zone stops growing.
Most of the engineering of RF ablation is about delaying roll-off. Internally cooled electrodes circulate chilled saline inside the needle, keeping the tissue at its surface below boiling so it does not char. The hottest point moves a few millimeters into the tissue, and the lethal isotherm moves outward with it. Multi-tine electrodes deploy an array of curved prongs from the needle, spreading the current over a larger volume. Generators control either temperature, from sensors in the tines, or impedance, pausing when it rises. Published manufacturer data give zones of 2.5–4 cm for a single cooled electrode and up to about 5 cm for multi-tine arrays.
Microwave ablation: heat in a volume
A microwave antenna does not need current to flow through tissue. It radiates an electromagnetic field at 915 MHz or 2.45 GHz, and the field acts directly on water molecules. Each water molecule is a small electric dipole, and in an alternating field it turns back and forth to follow the field, billions of times a second. It lags behind the field, jostling its neighbors as it turns, and the energy lost to that lag appears as heat. Ions in the tissue fluid, pushed back and forth by the same field, add losses of their own. Together these are dielectric heating, the physics of a microwave oven.
The field penetrates tissue far beyond the antenna's surface. In liver at 2.45 GHz, the wavelength is about 1.85 cm, against 12.2 cm in free space, and the power falls to 1/e of its value in about 1 cm; at 915 MHz the wavelength is about 4.7 cm and the power depth about 2 cm. These are figures for a plane wave; close to a thin antenna, power falls faster as the field spreads. Power is deposited through a volume a centimeter or two around the antenna rather than in a millimeter-thick shell, so the tissue heats faster, and reviews describe microwave zones as faster and hotter than RF zones, often above 100 °C.
The field also continues to heat tissue that has dried. Dry tissue absorbs microwaves less well, because it contains less water, but no conduction path is needed, so there is no roll-off in the RF sense. Microwaves also work in tissues that conduct poorly, such as lung and bone, and need no return pad. Several antennas can be run at once without competing for current, and one review reports that simultaneous antennas produced zones nearly six times the volume of a single one.
Current systems show the engineering choices. Medtronic's Emprint system runs at 2.45 GHz with 5–150 W, according to its FDA summary, and cools the shaft of its antenna with circulating saline. Ethicon's NEUWAVE system, in its 2013 FDA summary, feeds three independent amplifiers of up to 140 W each and cools its thin probes with carbon dioxide. The manufacturer of Emprint gives an ex vivo liver zone of 4.7 × 4.8 cm at 150 W in ten minutes. Cooling is needed because the coaxial cable and antenna themselves heat as they carry the power, and that heat would otherwise damage tissue along the needle track.
The choice between frequencies is a trade. A clinical comparison of 915 MHz and 2.45 GHz systems found similar results, but the 2.45 GHz system needed a mean of 4.0 minutes per burn against 8.1, and its zone sizes were more predictable. The systems also differed in power and antenna design, so not all of the difference is due to frequency. The higher frequency allows shorter antennas and more spherical zones; its cable losses are higher.
The heat sink, revisited
Chapter 2's heat sink hits RF ablation hardest, because RF relies on conduction for most of its zone. Microwave heating, deposited directly through a volume, is less affected, but not immune. In an ex vivo pig liver study with a perfused 5 mm vessel, with the antenna 10 mm from the vessel, the microwave ablation's radius was 37 % of its size without flow, and 80 % at 15 mm. For both energies, tumors against large vessels remain the hardest to ablate completely.
The heat-sink advantage of microwave ablation is real but partial. The study above used a 915 MHz system at 45 W, and data for current high-power 2.45 GHz systems near perfused vessels were not found for this guide. Planning should still allow for vessels near the target.
Judging the result
Neither RF nor microwave zones can be seen reliably while they form: gas from boiling tissue obscures ultrasound, and the heated tissue contracts, which distorts its apparent size. The result is judged afterwards on contrast-enhanced CT or MRI, where the dead zone no longer takes up contrast. The margin of dead tissue around the tumor on that scan predicts whether the tumor will recur locally, which is why ablation reports record it.
Manufacturer zone charts are measured in excised tissue without perfusion, at stated powers and times. They are the largest zones a system can make, not what it will make next to a vessel in a living liver. When comparing systems, compare the same tissue, the same power and time, and ideally perfused models; and remember that the zone must cover the tumor plus a margin, not the tumor alone.
- RF ablation deposits power in a shell a few millimeters thick around the needle and relies on conduction; charring at the needle raises impedance and stops the zone growing.
- Cooled and multi-tine electrodes delay roll-off; single cooled electrodes reach zones of about 2.5–4 cm in manufacturer data.
- Microwaves heat water directly through a volume about a centimeter deep, keep heating dried tissue, need no return pad, and make faster, hotter zones.
- Both energies lose ground next to large vessels; zones are judged after treatment on contrast imaging.
Cryoablation.
+ The questionEvery other energy adds heat. How does taking heat away kill tissue, and why is the edge you can see not the edge that dies?
Cooling by expansion
A cryoablation probe must get far colder than anything in the operating room, at the tip of a needle a couple of millimeters wide, without freezing the needle's shaft or the skin it passes through. Most systems do it with a property of real gases known as the Joule–Thomson effect. When a gas under high pressure expands through a narrow orifice without doing work on anything, its temperature changes. In most gases at room temperature, including argon and nitrogen, attraction between the molecules dominates: pulling them apart as the gas expands takes energy from their motion, and the gas cools. In helium at room temperature, repulsion dominates, and it warms.
In an argon cryoprobe, gas from a supply at about 3,200 psi flows down a thin capillary inside the needle to its tip, expands through an orifice into the closed tip chamber, and cools sharply. The cold gas absorbs heat through the tip wall from the surrounding tissue, then flows back along the space between the capillary and the outer wall and vents outside the patient. Argon boils at about −186 °C, which sets the floor; reviews report probe temperatures of about −150 to −160 °C for argon systems.
The same effect can therefore run the other way. Because helium warms when it expands, some systems thaw the tissue by switching the probe from argon to helium, while others use electrical heating instead. A third approach avoids high-pressure gas altogether: liquid-nitrogen systems circulate liquid at about 100 psi to the tip, where it boils: at −196 °C at atmospheric pressure, somewhat warmer under pressure. One such system, IceCure's ProSense, reports a minimum of −170 °C at the center of its cooling zone in its FDA decision summary.
How cold kills
Freezing kills cells in several ways at once. As tissue cools, ice forms first in the fluid between cells. The ice excludes salt, so the remaining fluid becomes more concentrated, and water is drawn out of the cells by osmosis; they shrink and their contents are damaged. If cooling is fast, water has no time to leave, and ice forms inside the cells themselves. Intracellular ice is far more damaging than extracellular ice, and at the probe, where cooling is fastest, it is the main cause of death.
Further from the probe, cooling is slower and the temperature higher, and cells may survive. There, injury depends on what happens next. During thawing, small ice crystals recrystallize into larger, more damaging ones, and water rushes back into shrunken cells. The small vessels of the frozen zone are injured, and in the hours after the procedure the tissue loses its blood supply. A review of cryoablation lists four factors that together decide injury: the cooling rate, the lowest temperature reached, the time held there, and the thawing rate.
The ice ball and its isotherms
A frozen zone has one great advantage over RF and microwave zones: it can be seen. Ice shows on CT and MRI, and on ultrasound as a bright near edge that shadows what lies behind it, so the operator watches the zone grow in real time. The catch is that the visible edge of the ice ball is the 0 °C isotherm, and cells at 0 °C survive. Reviews place reliable cell death below about −20 to −40 °C, and one describes the lethal −20 °C isotherm as lying at least 5 mm inside the visible edge.
A 2025 study quantified the gap for current needles. For single needles, the −40 °C isotherm spanned 44–60 % of the visible ice-ball width, depending on the system; clustering several needles raised the fraction. The practical rule follows: the visible ice must extend well beyond the tumor, by at least the distance between the visible edge and the lethal isotherm, if the whole tumor is to die.
Protocols usually freeze twice with a thaw between, because the second freeze meets tissue already damaged by the first and extends the lethal zone toward the edge of the ice. Reviews describe cycles such as ten minutes of freezing, eight of thawing and ten more of freezing for one argon system. For the breast, ProSense's FDA summary gives a default of nine minutes freezing, eight thawing and nine freezing, with target ice-ball widths of more than 35 mm after the first freeze and more than 40 mm after the second.
What cold gives and takes
Cryoablation's strengths follow from its physics. The zone is visible as it forms. There is no current through the patient and no return pad. Several probes can be combined to shape the ice around an irregular tumor.
Its weaknesses follow too. Cold does not coagulate blood, so frozen tissue has no built-in hemostasis, and a review notes a higher risk of bleeding after lung cryoablation than after RF ablation, which coagulates damaged vessels as it goes. Large vessels warm the ice nearby, a heat source rather than a heat sink, and vessels wider than about 3 mm distort the ice ball. And the logistics are real: argon systems need high-pressure cylinders and gas lines, which is part of the case the makers of liquid-nitrogen systems make for theirs.
Regulatory history shows cryoablation extending into new territory. On 3 October 2025, FDA granted IceCure's ProSense a De Novo authorization, DEN220077, for the local treatment of biologically low-risk breast cancers of 1.5 cm or less in patients aged 70 or over who receive adjuvant endocrine therapy. The FDA's analysis of the supporting trial reported ipsilateral recurrence rates of 2.3–8.7 %, depending on the analysis population; the manufacturer reports a five-year estimate of 3.1 %. The difference between those figures is a lesson in reading results: each is correct for its own population and method.
The ice ball's edge is the easiest thing in ablation to see and the easiest to misread. It marks 0 °C, not death. A plan that covers the tumor with visible ice, but not with the lethal isotherm, leaves a rim of living tumor inside what looked like a successful freeze.
Reading a cryoablation system's specifications means asking which isotherm a stated zone size refers to. A "4 cm ice ball" and a "4 cm lethal zone" are very different claims. Zone charts that give the −20 °C and −40 °C isotherms, measured for single and clustered needles, are the ones that allow a plan to be made.
- Cryoprobes cool by Joule–Thomson expansion of high-pressure argon, about 3,200 psi, or by circulating liquid nitrogen; helium or electrical heating thaws.
- Freezing kills by extracellular ice and osmotic injury, by intracellular ice where cooling is fast, and by vascular injury after thawing.
- The visible ice edge is 0 °C; reliable death lies below −20 to −40 °C, at least about 5 mm inside, so the ice must extend beyond the tumor by that margin.
- Cryoablation gives a visible zone and no current through the patient, but no hemostasis; its newest US indication is low-risk breast cancer in older patients.
Pulsed fields: IRE and PFA.
+ The questionHow can kilovolt pulses kill cells without heating them, and why would anyone want an ablation that does not use heat?
The problem heat cannot solve
Every energy so far kills by temperature, and temperature does not discriminate. A tumor wrapped around the portal vein, a prostate cancer beside the nerves and sphincter that control erection and continence, the wall of the left atrium lying against the esophagus: in each case the cells to be killed sit next to structures that must survive, and heat destroys both alike. The collagen framework of a vessel or duct, which survives many other insults, is destroyed at the temperatures ablation reaches, along with the cells around it.
Pulsed electric fields offer a different mechanism. Very short, very strong electric pulses open holes in cell membranes. If the holes are large and numerous enough, the cell cannot repair them and dies, while the extracellular scaffold of collagen and elastin, which has no membrane, is left intact. The technique is called irreversible electroporation (IRE) in tumor ablation and pulsed field ablation (PFA) in cardiology.
A voltage across the membrane
Chapter 3 described a cell as a conducting interior wrapped in an insulating membrane. Put such a cell in an external electric field and charge piles up on the membrane: positive on one side, negative on the other. Within about a microsecond, the voltage across the membrane settles at a value that depends on the field, the cell's size and the position on the cell. For a spherical cell of radius R in a field E, the induced voltage is 1.5 × E × R × cos θ, where θ is the angle from the field direction. It is largest at the two poles facing the field and zero at the equator.
For a cell of radius 5 µm, a field of 400 V/cm induces 1.5 × 40,000 V/m × 0.000005 m = 0.30 V at the poles. At 600 V/cm it is 0.45 V; at 1,000 V/cm, 0.75 V. Membranes are reported to open pores once the induced voltage exceeds about 0.5–1 V.
Above that threshold, the membrane's lipid layer rearranges into nanometer-scale pores. After a brief, mild exposure the pores reseal and the cell survives: this is reversible electroporation, used to push drugs or DNA into cells. After stronger or more numerous pulses the damage is beyond repair and the cell dies over the following hours. The formula also shows why cell size matters: a larger cell reaches the threshold at a lower field.
Thresholds and the shape of the zone
The field around a pair of needle electrodes is strongest between and immediately around them and falls off with distance, so the ablation zone is the region where the field exceeds the irreversible threshold for that tissue. A compilation of published measurements gives mean irreversible thresholds, in volts per centimeter, of 539 for liver, 538 for kidney, 585 for brain, 700 for prostate and 1,050 for bone. A modeling study used about 360 V/cm as the lower, reversible threshold in liver. The thresholds fall as more and longer pulses are delivered. Clinical IRE applies 1,000–3,000 V for each centimeter between electrodes placed no more than 2 cm apart, so that the field across the target stays above threshold with margin.
Because the mechanism is electrical, not thermal, flowing blood does not carry the effect away. There is no heat sink, and the zone reaches right up to the wall of a vessel crossing it. Reviews report that vessels, bronchi and probably bile ducts within the zone are preserved. That is the reason to use IRE: it can treat tissue that heat-based ablation cannot safely reach.
IRE pulses carry a lot of energy. The manual of one IRE generator gives outputs of 500–3,000 V and up to 50 A, in pulses of 20–100 µs, with up to about 15 J per pulse. Every pulse deposits some Joule heat, and near the electrodes, after many pulses, tissue can heat enough to add thermal injury. Non-thermal describes the mechanism that kills most of the zone, not an absence of heating.
Pulses and the heart
Pulses of thousands of volts stimulate every nerve and muscle they reach, and can trigger the heart. IRE therefore needs two precautions. Pulses are synchronized with the ECG and delivered in the heart's refractory period, just after each heartbeat, when it cannot be triggered; the generator described above delivers up to 90 pulses a minute in this mode. And because the pulses make skeletal muscle contract violently, patients are treated under general anesthesia with complete neuromuscular block.
Cardiac PFA solved the same problem differently. It uses short biphasic pulses, alternating positive and negative, which stimulate muscle much less than long monophasic pulses and are considerably less likely to trigger arrhythmias. One published review describes a current system delivering 1.8–2 kV in trains of pulses within applications lasting a few seconds.
Pulsed field ablation for atrial fibrillation
The most rapid adoption of any energy in this guide is happening in cardiology. Atrial fibrillation is treated by creating lines of scar around the pulmonary veins, and for decades that was done with RF heat or with cold. Both carry a small risk of injuring the esophagus, which lies against the back of the left atrium, and the phrenic nerve, which runs near the right-sided veins. Heart muscle has a comparatively low irreversible threshold, measured at a median of 416 V/cm in human donor hearts with biphasic pulses. A proposed explanation for PFA's selectivity is the cell-size effect: atrial muscle cells are 10–15 µm across, esophageal smooth-muscle cells 3–10 µm and nerve fibers 1–5 µm, so heart muscle crosses the threshold first.
FDA approved the first PFA system, Medtronic's PulseSelect, on 13 December 2023, followed by Boston Scientific's FARAPULSE on 31 January 2024, Medtronic's Affera Sphere-9, which delivers both pulsed field and RF energy, on 24 October 2024, and Johnson & Johnson's Varipulse on 7 November 2024. Johnson & Johnson paused US cases with Varipulse in January 2025 after neurovascular events and announced a limited restart in February, with updated instructions for use. In a registry of 17,642 patients treated with one system, there were no esophageal complications and no persistent phrenic nerve palsy, and major complications occurred in 0.98 %.
Measures of adoption depend on what is counted. US purchasing data put PFA at 69 % of spending on AF ablation catheters in 2025 and 78 % in early 2026, but at 48 % and 57 % of catheter units; a physician survey projected 49 % of procedures in 2025. All three can be accurate; they measure different things.
IRE for tumors has moved more slowly. AngioDynamics' NanoKnife had long been cleared by 510(k) for the surgical ablation of soft tissue; a clearance announced on 9 December 2024 extended that indication to name prostate tissue. The US indication names the tissue, not the disease, a distinction that matters in reading any device's label.
For a pulsed-field device, the field map is the design. The electrode geometry, the pulse amplitude, width, number and polarity, and the tissue's threshold together decide where the zone ends; heating near the electrodes decides whether the zone is purely non-thermal. Verifying a pulsed-field system therefore means measuring zone size and thermal effects across the range of pulse settings, not only the generator's electrical output.
- An external field induces a membrane voltage of about 1.5 × field × radius; above about 0.5–1 V pores open, and after enough pulses the cell cannot recover.
- Irreversible thresholds are several hundred volts per centimeter and vary by tissue; the zone is where the field exceeds the threshold, with no heat sink.
- The collagen scaffold of vessels and ducts survives, which is the reason to use pulsed fields; pulses still deposit some heat near the electrodes.
- IRE pulses are ECG-synchronized under full muscle relaxation; cardiac PFA uses biphasic pulses and has been adopted rapidly since its first US approval in December 2023.
Focused ultrasound: HIFU and histotripsy.
+ The questionEvery energy so far reaches tissue through a needle, an instrument or an incision. How can sound destroy tissue deep inside a closed body without breaking the skin?
Bringing sound to a point
Chapter 4 showed that sound travels through soft tissue with little reflection and moderate absorption. A focused transducer uses both facts. Its surface is curved like the inside of a bowl, or made of many elements driven in carefully timed sequence, so that sound leaving every part of it arrives at one point in phase. Spread over the large area of the transducer and the skin beneath it, the intensity is modest; concentrated at the focus, it can be thousands of times higher.
The focal zone is not a point but an elongated spot, narrow across the beam and longer along it, with dimensions set by the wavelength and the geometry. FDA's decision summary for the Sonablate prostate system, which operates at 4 MHz, describes a single lesion about 10–12 mm long and 1–2 mm wide, at focal intensities of 1,200–2,000 W/cm². Larger volumes are treated by moving the focus and laying lesions side by side, under imaging.
Everything in the path matters. Chapter 4's reflection figures reappear as rules: gas in bowel or lung reflects 99.9 % of the sound and blocks it; bone reflects about two fifths, absorbs much of the rest and heats; fat attenuates. One review reports that perinephric fat reduced the energy delivered from 58 % at 2 cm depth to 26 % at 5 cm. Treatment therefore needs an acoustic window, a path of soft tissue free of gas and bone, and planning centers on finding one.
Thermal HIFU
In high-intensity focused ultrasound, or HIFU, the sound absorbed at the focus heats it. Exposures last seconds; the Sonablate summary describes three seconds on and six off. Focal temperatures rise well above the 56–60 °C often quoted for death within about a second (Chapter 1 shows how much that time varies by tissue), and reviews report temperatures above 80 °C. Because the focus is small and heating is rapid, the lesion boundary is sharp, and tissue a few millimeters away is spared.
The advantages of an incision-free treatment are balanced by constraints. Each lesion is small, so large volumes take time. The heat is still heat, so perfusion and the heat sink of Chapter 2 apply, and nearby sensitive structures still need protection. Guidance matters: systems guided by MRI can map temperature in the tissue during treatment, while ultrasound-guided systems see the anatomy in real time but have no direct thermometry.
In the US, focused ultrasound was first approved in 2004, by premarket approval, for an MRI-guided system that treats uterine fibroids. For the prostate, FDA granted the Sonablate 450 a De Novo authorization on 9 October 2015, creating a new regulation for high-intensity ultrasound systems for prostate tissue ablation. EDAP, the maker of a competing system called Ablatherm, then withdrew its De Novo request and filed a 510(k) using Sonablate as its predicate, and Focal One, a later system from the same company, received 510(k) clearance on 7 June 2018. The sequence shows how the US system works: the first device of a new kind creates a classification, and later ones follow it. The international safety standard for such equipment is IEC 60601-2-62, first published in 2013, although Sonablate's summary cites the diagnostic ultrasound standard, IEC 60601-2-37, instead.
Histotripsy: sound without heat
Histotripsy uses the same focused sound in a completely different way. Instead of long exposures that let heat accumulate, it fires pulses lasting microseconds, at duty cycles below 1 %, with peak negative pressures high enough to produce inertial cavitation at the focus. Chapter 4 put the intrinsic threshold at about 25–30 MPa for single-cycle pulses. A cloud of bubbles forms, grows and collapses with each pulse, and the repeated collapses break the cells apart; the body then clears the debris. With so little time on, the tissue barely warms.
The mechanism has three useful consequences. There is no heat sink, because heat is not the agent. Collagen-rich structures such as vessels and bile ducts are more resistant to the mechanical stress than the cells around them, and preclinical reviews report that vessels larger than about 1 mm are preserved. And the bubble cloud is bright on ultrasound, so the treatment can be watched as it happens.
HistoSonics' Edison system, which a published review describes as operating at 700 kHz with pulses shorter than 20 µs and duty cycles below 1 %, received a De Novo authorization from FDA on 6 October 2023 for the destruction of liver tumors, including unresectable ones, by a non-thermal, mechanical process. In the pivotal trial, technical success was 95.5 %, in 42 of 44 tumors, and major complications occurred in 3 of 44 patients at 30 days. The trial treated tumors smaller than 3 cm, required an adequate acoustic window, and kept the main portal vein, main bile ducts, gallbladder, stomach and bowel out of the treatment volume.
The company announced on 11 May 2026 that it had filed a De Novo request for kidney tumors. As of September 2026, no FDA decision has been announced.
Press coverage of new energies often runs ahead of regulators. A De Novo request or a 510(k) submission is an application; only FDA's decision makes a device legally marketable for that use. Histotripsy for liver is authorized in the US; histotripsy for kidney, as of this guide, is filed and pending.
HIFU and histotripsy can use similar transducers, focused through the same windows, and differ mainly in timing and peak pressure. Long exposures let heat build: coagulation. Microsecond pulses at under 1 % duty cycle leave no time for heat but pull hard enough to cavitate: mechanical fractionation. In principle, the same transducer, driven differently, becomes a different energy.
- A focused transducer concentrates sound at a small elongated focus deep in the body while keeping intensity low along the path; gas and bone must be avoided.
- Thermal HIFU heats the focus above about 60–80 °C in seconds; lesions are small, so volumes are treated lesion by lesion.
- Histotripsy fires microsecond pulses above the cavitation threshold at under 1 % duty cycle, fractionating cells mechanically with little heat and no heat sink.
- Sonablate (2015) and Edison (2023) were authorized by De Novo; later prostate systems followed by 510(k); histotripsy for kidney was filed in May 2026 and is pending.
+ Part VI · The case
One operation.
The physics and the instruments are now in place. This part puts them to work in a single, common operation, and uses it to answer the first half of the guide's question: why one operation, on one patient, calls for several energies, and what each is doing that the others could not.
One operation, several energies.
+ The questionIn a single laparoscopic colectomy, which energy does each step use, and why that one rather than another?
The operation
A right hemicolectomy removes the right side of the colon, usually for cancer, together with the fat, lymph nodes and blood vessels that supply it. Done laparoscopically, it follows a sequence that varies with the surgeon and the anatomy but has a common shape. The description below is a typical medial-to-lateral approach, written to show where energy is used, not as a surgical technique.
The surgeon first places the ports and inspects the abdomen. The peritoneum, the thin membrane covering the mesentery, is opened along the ileocolic vessels, which supply the end of the small bowel and the start of the colon. Those vessels are divided at their origin. The mesentery is then lifted off the duodenum and pancreas behind it, in a natural tissue plane. The rest of the mesentery, including the right branch of the middle colic vessels, and the omentum are divided. The hepatic flexure, where the colon turns beneath the liver, and the attachments along the side of the abdomen are freed. Finally the bowel is divided on either side of the tumor and the two ends are joined, usually with staplers.
Seven steps, and in a typical case two or three energies and one or two kinds of mechanical closure. The choice at each step is the physics of the earlier chapters applied to a specific tissue.
Opening planes: monopolar
Opening the peritoneum and developing the plane behind the mesentery is dissection through thin, largely avascular tissue. It needs precision, speed and visibility, and it rarely needs to seal anything larger than a capillary. A monopolar hook or scissors does this well. At cutting voltages, the arc of Chapter 8 divides the membrane in a clean line; switched to coagulation, the same instrument stops oozing from small vessels. The instrument is thin, cheap and precise.
The costs are the ones Part VII describes. The current crosses the patient to the return pad, and anywhere along the shaft that insulation is damaged, energy can leave the instrument; wherever the shaft runs through a cannula, current couples across even intact insulation, and a hybrid cannula can discharge it into bowel. In this step the shaft works close to the duodenum and small bowel. The waveform matters too: a coag waveform at several kilovolts peak, activated near bowel or in open air, is the setting most likely to couple energy where it is not wanted.
Dividing vascular tissue: sealing and ultrasonic energy
The mesentery and the omentum carry vessels of a few millimeters, too many to clip one by one and too large to trust to monopolar coagulation. This is the work of advanced bipolar sealers and ultrasonic shears. Each grasps a bite of tissue, seals the vessels in it and divides it, so the surgeon can walk along the mesentery bite by bite without changing instruments.
The two approach the same job from different physics. A bipolar sealer fuses collagen with current under high jaw pressure, is indicated for vessels up to 7 mm, and ends each seal by itself on an impedance end point, with thermal spread of about 1.3–2.1 mm in manufacturer-authored studies. An ultrasonic shear seals and cuts by friction with no current through the patient, is indicated for vessels up to 5 mm, or 7 mm for newer designs, and dissects precisely, but its blade stays hot after each activation. Surgeons choose between them, or use a hybrid, according to the tissue, the step and experience, and the choice is less about which is better than about which physics suits that moment.
The robotic version of the operation makes the same choice with different instruments. Intuitive's SynchroSeal, which seals and cuts at the same time, is indicated for vessels up to 5 mm; in a preclinical study by the manufacturer, it produced burst pressures of about 1,160 mmHg with thermal spread of 1.2–1.5 mm, and a peak jaw temperature of about 110 °C, against about 247 °C for an ultrasonic comparator in the same study.
The largest vessels: a decision
The ileocolic artery and vein are usually the largest vessels divided in a standard right hemicolectomy. Here the surgeon has a real choice: a sealer used within its labeled vessel size, or a mechanical closure with clips or a vascular stapler. The physics of Chapter 9 frames the decision. A seal's strength falls sharply beyond the indicated size, and a failed seal on a main vessel is a serious bleed. A clip or staple does not depend on tissue impedance or collagen content, but it adds an instrument and a device left in the body. Many surgeons use energy up to a size and mechanical closure above it; the size at which they switch is a clinical judgment the guide does not make.
The bowel itself is divided and joined with staplers rather than energy: it is thick, it contains bacteria and gas, and its ends must be joined reliably. Energy may open the small holes for the stapler; otherwise, near the bowel it is a hazard to manage rather than a tool.
What the generator saw
Take one bite of mesentery, sealed with an advanced bipolar device. From the generator's side, the seal is a few seconds of electrical measurements. It senses the tissue with a brief low-level signal, then drives power at its setting while the impedance dips as the tissue warms. As water boils off and the impedance climbs, the output reaches its voltage limit and the delivered power falls. When the impedance curve shows the water has gone, the generator stops, waits while the seal cools in the closed jaws, and sounds a tone.
Nothing in that record measures the seal. The generator knows voltage, current and time, and infers the rest through an algorithm tuned on bench and animal tests. The surgeon hears a tone and opens the jaws. Whether seals of this kind hold against arterial pressure while the vessel heals was tested before the device was sold, by the burst tests, histology and chronic animal studies of Chapters 9 and 21.
The answer, so far
This operation, with Parts III to V behind it, answers the first half of the guide's question: why eleven energies. Surgery needs eleven energies because its tasks need heat in different geometries and at different speeds, some need the tissue scaffold to survive and so need no heat at all, and where two energies meet the same need, each trades a different weakness.
| Task | What the physics needs | Energy that fits |
|---|---|---|
| Open a thin plane | a moving line of vaporization, fast and narrow | monopolar cut |
| Coagulate a bleeding surface | shallow coagulation over an area | monopolar coag or spray |
| Coagulate a small vessel precisely | current confined between two tips | conventional bipolar |
| Seal and divide vascular tissue | collagen fusion under pressure, with an end point | advanced bipolar, ultrasonic or hybrid |
| Close the largest vessels | a mechanical closure that does not rely on heating the tissue | clips or staplers, or a sealer within its size |
| Vaporize a thin layer precisely | shallow absorption, short pulses | CO₂ laser |
| Break a stone under water | pulsed energy through a vapor channel | holmium or thulium laser |
| Kill a tumor in place | a lethal volume several centimeters across | RF, microwave or cryoablation |
| Kill cells but spare vessels and ducts | a non-thermal mechanism | IRE, PFA or histotripsy |
| Treat without an incision | a focus deep inside intact tissue | HIFU or histotripsy |
Each row asks for a geometry, a speed or a mechanism that the others cannot provide. Where a row names more than one energy, they differ in a second property: microwave keeps heating past RF's roll-off and is less affected by the heat sink; cryoablation shows its zone as it forms but gives no hemostasis; ultrasonic energy keeps current out of the patient.
The second half of the question, putting the effect exactly where it is intended and nowhere else, is where the rest of the guide goes. The energy that leaves the instrument before it reaches the tip, the smoke and light that leave the patient, and the evidence a device must produce before it is sold are the subjects of Parts VII and VIII.
Randomized comparisons of energy devices in laparoscopic colorectal surgery exist; this guide has not reviewed them and does not rank devices or recommend a technique. It explains why each energy suits the steps it is used for.
- A laparoscopic right hemicolectomy typically uses monopolar energy for planes, advanced bipolar or ultrasonic devices for vascular tissue, a sealer within its size, or clips or a stapler, for the largest vessels, and staplers for the bowel.
- Each choice follows the physics: fast narrow vaporization for dissection, collagen fusion for sealing, mechanical closure where tissue-dependent sealing is least reliable.
- The generator infers each seal from voltage, current and impedance; seal strength is established by testing before sale.
- Surgery needs eleven energies because tasks need heat in different geometries and speeds, some need no heat at all, and where two energies meet one need, each trades a different weakness.
+ Part VII · The patient and the room
Where else the energy goes.
An energy device is designed to act at its tip. These two chapters follow the energy that goes elsewhere: current that leaves an instrument before it reaches the tissue, and the smoke, light, sparks and electrical noise that leave the patient altogether. Each is a direct consequence of physics met earlier, and each has an engineering answer.
Burns away from the tip.
+ The questionHow can electrosurgical energy burn tissue that no instrument ever touched?
Three stray paths
Chapter 3 established that heat appears wherever current is concentrated, and Chapter 7 that most of a laparoscopic instrument lies out of the camera's view. Put those together and the problem of stray energy follows. Current can leave a monopolar instrument before it reaches the tip in three ways, and each can burn bowel where nobody is looking.
Direct coupling. The active electrode touches another conductor, such as a metal grasper or the laparoscope, which in turn touches tissue. Current flows through the second instrument and heats tissue at its contact point, wherever that is.
Insulation failure. A break in the insulation of the shaft, from wear, reprocessing or rough handling, exposes the conductor. If tissue lies against the defect, current flows out through a tiny area, and the density there can be as high as at the tip.
Capacitive coupling. Even with perfect insulation, a conductor inside a metal cannula forms a capacitor, and alternating current flows across it without any contact at all.
The injuries are uncommon but serious. A review in 2000 put electrosurgical injury at two to five per thousand laparoscopic procedures in the 1990s, and a 2021 review gives 3.6 per thousand. Many are not recognized during the operation. As Chapter 1 explained, coagulated bowel wall can look almost normal when the instrument leaves it, then die and perforate days later.
Insulation that fails out of view
Insulation defects are not rare. A 2023 study found defects in 11.6 % of reusable laparoscopic instruments tested, and earlier series report figures between 15 and 27 %. Robotic instruments fare worse: a prospective study found insulation failure in 32 % of robotic instruments against 13 % of laparoscopic ones, rising after ten uses to 80 % against 36 %, and 81.7 % against 19.5 % in a later phase of the same study.
A defect needs voltage to become a burn. High-voltage coag waveforms, at thousands of volts peak, drive current through small defects, and even through thin insulation that is intact but stressed, far more readily than a cutting waveform, whose peak voltage is several times lower. That is why IEC 60601-2-2 tests the insulation of active accessories at high frequency, at 120 % of the accessory's rated voltage for 30 seconds, and ties the test waveform's crest factor to the voltage rating: an accessory rated for high voltage must survive a waveform like the one it will carry.
The cannula as a capacitor
Capacitive coupling can be estimated from school physics. An insulated conductor inside a metal tube is a cylindrical capacitor, with a capacitance that depends on the length engaged and the ratio of the tube's radius to the conductor's.
Take a 5 mm instrument: a conductor of radius 2.25 mm, insulation 0.25 mm thick with a relative permittivity of about 2.1, pressed against a metal cannula. For 10 cm of shaft, C = 2π × ε₀ × 2.1 × 0.1 m ÷ ln(2.5 ÷ 2.25) ≈ 110 pF. A 0.25 mm air gap lowers this to about 40 pF, and 30 cm of shaft near metal raises it to about 330 pF; 50–200 pF is taken as typical. At 500 kHz, a capacitor of 50–200 pF has a reactance of a few kilohms: 50 pF gives about 6.4 kΩ. The coupled current is the voltage divided by that reactance. At 300 V RMS, a cut into 300 Ω at 300 W, 50–200 pF passes about 47–188 mA. At the maximum of a fulguration or spray waveform, about 640 V RMS and 3.4–3.9 kV peak, it passes proportionally more.
The estimate is an upper bound, because a generator limits its own output, but it matches independent evidence. A 1994 patent on active electrode monitoring gives normal capacitive currents in an instrument shield of 50–250 mA RMS. Coupled current rises with voltage, with frequency and with capacitance, which is why coag waveforms and activation in open air, when no tissue loads the generator and its voltage rises to its maximum, drive the most current through the cannula.
Where that current goes depends on the cannula. An all-metal cannula held in the abdominal wall passes the coupled current into the wall over a broad contact, where its density is low and it returns harmlessly. A hybrid cannula, a metal tube held in a plastic anchor, is the dangerous combination: the metal collects the charge, the plastic insulates it from the wall, and it discharges into whatever touches the metal, which may be bowel. FDA's electrosurgical guidance asks manufacturers to test capacitive coupling to a conductive cannula and to warn against hybrid trocars.
Engineering answers
Active electrode monitoring addresses both insulation failure and capacitive coupling. The instrument's shaft carries a conductive shield around the insulated conductor, connected back to the generator's return, with a second layer of insulation outside it. Any current escaping the conductor, through a defect or by capacitance, is collected by the shield and returned safely, and a monitor measures it. The same patent, filed in 1991, describes a monitor that distinguishes normal capacitive current, 90° out of phase with the voltage, from the in-phase current of a fault, and stops the generator if a fault appears.
The other answers are procedural and belong in instructions for use and training: inspecting insulation, using the lowest effective voltage, preferring cutting to coag waveforms where they work, never activating in open air, keeping the whole active electrode in view where possible, and avoiding hybrid cannulas. Chapter 19 lists some that have become design features, such as low-voltage modes and activation that cannot occur accidentally.
Pad burns, and what surgeons know
The return pad is the other place where monopolar current can burn away from the tip, and Chapter 8 described the physics: a pad that lifts concentrates current at its remaining edge. IEC 60601-2-2 adds a further safeguard for outputs that can deliver large currents for long periods. An output able to exceed a heating factor of 30 A²s in any 60 seconds counts as a high current mode, with stricter requirements for the return electrode, and the 2023 amendment asks for heating under the return electrode to be assessed even below that level.
Knowledge is part of the system. A knowledge test of leaders of the Society of American Gastrointestinal and Endoscopic Surgeons, reported in 2012, found a median score of 59 %, and 31 % did not know the correct response to an operating-room fire; the society launched its Fundamental Use of Surgical Energy (FUSE) program in 2014.
Everything in this chapter happens away from the tip, and most of it out of view. A device that looks perfectly controlled on the monitor can still be delivering energy somewhere else. Testing, monitoring and design must cover the whole path from generator to return, not only the working end.
- Current can leave a monopolar instrument by direct coupling, insulation failure or capacitive coupling, and burn tissue out of view; injuries may present days later.
- Insulation defects are common in reusable instruments and more common in robotic ones; high-voltage waveforms drive current through them most readily.
- A shaft inside a metal cannula is a capacitor of roughly 50–200 pF that passes tens to hundreds of milliamperes; hybrid cannulas can discharge it into bowel.
- Active electrode monitoring, insulation testing, lower voltages and correct cannula choice are the engineering and procedural answers.
Smoke, fire, light and implants.
+ The questionBeyond the patient's tissue, what does surgical energy do to the air, the eyes, the monitors and the implants around it?
Smoke
Chapter 1 showed that cutting boils the water in cells until they burst, and that dried tissue chars. Both release the cell's contents into the air as a plume, and the plume is not harmless steam. Reviews of surgical smoke report more than 80 chemical compounds in it, including benzene, formaldehyde, acrylonitrile and polycyclic aromatic hydrocarbons, and viral DNA has been detected in plume from the treatment of papillomavirus lesions. In 1981, a study compared the mutagenicity of smoke with that of cigarettes and found that the smoke from one gram of tissue matched about six cigarettes for electrocautery and three for a CO₂ laser. OSHA estimates that around 500,000 US workers are exposed to laser or electrosurgical smoke each year.
The particles are small. The mean aerodynamic size of electrosurgical smoke particles is reported at about 0.07 µm, and of laser plume about 0.31 µm, well under the size of a bacterium. Ultrasonic devices produce an aerosol mechanically rather than by combustion. One study pooling electrosurgery, ultrasonic and high-speed cutting found half of all particles smaller than 2.72 µm and 90 % smaller than 10 µm; it did not report sizes by device. Particles this small follow the air and reach deep into the lungs.
Because the particles follow the air, the effective control is to capture the plume at its source. NIOSH guidance from 1996 calls for local exhaust ventilation with a capture velocity of 100–150 feet per minute at a nozzle held within 2 inches of the site, with high-efficiency filtration. In laparoscopy the same problem appears inside the abdomen, where smoke obscures the camera and must be removed without losing the gas pressure that holds the wall up. FDA's electrosurgical guidance asks manufacturers to label the hazards of smoke and the use of effective evacuation. As of September 2026, 22 US states had enacted laws requiring surgical smoke evacuation, according to the Association of periOperative Registered Nurses.
Fire
A fire needs three things at once: an oxidizer, a fuel and a source of ignition. An operating room supplies all three in abundance. The oxidizer is oxygen, often concentrated under surgical drapes or around the airway, and nitrous oxide. The fuels include alcohol-based skin preparations, drapes, gauze, hair, the airway tube itself and the gas in bowel. The ignition source is usually an energy device.
Pennsylvania's patient-safety reports give a picture of the pattern. Of 28 surgical fires reported between July 2011 and June 2016, electrosurgery was the ignition source in 79 %, and about two thirds occurred in the head or neck, where oxygen is delivered close to the surgical site. Reports fell by 44 % against the previous five years. ECRI has found that oxygen-enriched atmospheres contribute to about 70 % of surgical fires.
Every side of the triangle has a control. The anesthesia team can keep open oxygen delivery near the surgical site at 30 % or less, a threshold traced to investigations in the late 1970s, and avoid nitrous oxide. Alcohol preparations must dry completely before drapes go on. Energy devices can be used at the lowest effective setting and kept in holsters when not in use. In the airway, laser surgery uses laser-resistant tubes whose cuffs are filled with saline. In endoscopy of the colon, a European guideline notes the risk of gas explosion when methane exceeds 5 %, hydrogen 4 % and oxygen 5 %.
Light
Surgical lasers are Class 4 lasers, the highest hazard class: hazardous to view directly or by reflection, and able to ignite materials. Along the direct beam, the hazard to the eye extends as far as the exposure stays above the eye's maximum permissible exposure, a distance called the nominal ocular hazard distance. Reflections and focusing optics define a wider nominal hazard zone around the laser.
That distance can be surprisingly large. The manufacturer of one 180 W, 532 nm system states a nominal ocular hazard distance of 33.9 m and requires eyewear with an optical density of at least 6 at 532 nm. For one holmium system with a bare fiber, the manufacturer states 1.6 m and an optical density of 3. OSHA's technical manual works an example of a 100 W Nd:YAG laser: 1.4 m for diffuse reflection, 11.3 m through a lens, and 1,410 m for the direct beam. Where the distance exceeds the room, as it often does, the whole room is the hazard zone and everyone in it wears eyewear rated for the wavelength.
Two standards govern laser safety. IEC 60825-1 classifies laser products and sets requirements; its current edition is from 2014. In the US, laser products must also meet the federal laser performance standard, 21 CFR 1040.10 and 1040.11; FDA's Laser Notice 56, issued in 2019, allows manufacturers to conform to the 2014 edition of IEC 60825-1, together with IEC 60601-2-22 for medical lasers, in place of most of those requirements. IEC 60601-2-22 sets the particular requirements for medical lasers; its fourth edition dates from 2019, and an amendment was published in April 2026.
Implants and monitors
Current flowing through the patient is also electrical noise, and it can disturb devices that sense the body's own electrical signals. Pacemakers and implantable defibrillators are the most important. Their leads pick up voltages, and electrosurgical current passing near the heart can be misread as cardiac activity, inhibiting pacing or triggering a defibrillator.
The European endoscopy society's technical guideline sets out the usual precautions. Bipolar energy is preferred where it will do. If monopolar energy is needed, the return pad is placed so that the current path does not cross the pacemaker and heart, and a pure cutting waveform may be preferable. The device may be reprogrammed by qualified staff, or a magnet used where the device supports it, and continuous ECG monitoring and a defibrillator are kept ready. More detailed recommendations come from the consensus statement of the Heart Rhythm Society and the American Society of Anesthesiologists. Ultrasonic energy, which passes no current through the patient, avoids this interference altogether.
The operating room's own monitors are affected too, most visibly the ECG, which shows interference whenever electrosurgery is active. Electromagnetic compatibility testing under IEC 60601-1-2, as modified by IEC 60601-2-2 for electrosurgical equipment, limits a device's unintended emissions and sets how much interference it must tolerate. The intended output, a strong high-frequency current in the patient, cannot be designed away; it can only be kept where it belongs.
Smoke, fire, light and electromagnetic interference are usually treated as the operating room's problems, but each has a device side. Evacuation ports and filters, activation that cannot occur accidentally, holsters, low-voltage modes, fiber and beam interlocks, eyewear specifications in the labeling, and emissions within IEC 60601-1-2 limits are all design and labeling decisions, and each appears in the risk file.
- Surgical smoke contains more than 80 compounds and particles averaging 0.07 µm for electrosurgery; capture at the source is the effective control, and 22 US states now require it.
- Surgical fires need oxidizer, fuel and ignition together; electrosurgery was the ignition in 79 % of Pennsylvania reports, and limiting open oxygen to 30 % is the key control.
- Surgical lasers are Class 4; their eye-hazard distance can exceed the room, so everyone present wears eyewear rated for the wavelength.
- Electrosurgical current can interfere with pacemakers, defibrillators and monitors; bipolar or ultrasonic energy, pad placement and device management reduce the risk.
+ Part VIII · From design to market
Proving it.
A surgical energy device reaches an operating room only after its maker has shown, to standards and to regulators, that it does what it claims and nothing else. These four chapters follow that proof: the safety architecture a generator needs, the tests that check it, the regulatory routes in the US, the EU and India, and what is changing.
The generator as a system.
+ The questionWhat has to be true of a surgical generator, beyond delivering the right energy, before it can safely touch a patient?
Basic safety and essential performance
The general standard for medical electrical equipment, IEC 60601-1, organizes safety around two ideas. Basic safety is freedom from unacceptable risk from physical hazards when the equipment is used normally or fails in a reasonably foreseeable way: electric shock, fire, mechanical injury, excessive temperature. Essential performance is the performance the device must maintain for the patient to be safe, as identified by the manufacturer's risk analysis.
For a surgical generator, essential performance is largely a statement about energy. The output must match the setting within its declared limits, it must not appear when it has not been commanded, and it must stop when commanded. A generator that delivers too much energy, or any energy at the wrong moment, injures someone even if it never shocks anyone. The rest of this chapter follows from making those statements true under fault conditions.
A second channel that can stop everything
IEC 60601-1 requires equipment to remain safe after any single fault, such as a failed component, a stuck switch or a software error. A generator's controller cannot be the only thing standing between a fault and an unintended output, because the controller may be what has failed. Generators are therefore built with two channels.
The control channel is the one described in Chapter 10: the user interface, the controller, the power stage and the sensors that close the loop on the output. The safety channel runs alongside it, with its own sensors on the output and its own logic, independent of the controller. It checks that the output matches what was commanded, that nothing is delivered without activation, and that the return pad monitor and other interlocks are satisfied, and if not it disables the power stage directly, without asking the controller. A Valleylab patent filed in 1981 already describes a return pad monitor that disabled the generator; modern designs extend the same principle to the output itself.
Around the channels sit the indicators and alarms the operator relies on. Activation produces a tone and a light, and IEC 60601-2-2 specifies the colors used for warnings and for cut, coag and ready states, a table its 2023 amendment redesigned. Alarms follow the collateral standard for alarm systems, IEC 60601-1-8.
Insulation barriers and leakage
A generator connects to the mains on one side and to the patient on the other, and must keep the two apart even after a fault. IEC 60601-1 does this with means of protection: insulation, clearances through air and creepage distances along surfaces, each rated for a test voltage. Protection of the operator and protection of the patient are rated separately and differently. One means of patient protection, for mains up to about 250 V, is commonly quoted as a test at 1,500 V AC with 4 mm of creepage and 2.5 mm of clearance; two means of patient protection, as a test at 4,000 V AC with 8 mm and 5 mm.
The standard then limits the current that may leak through those barriers. The parts that contact the patient are classified as type B, BF or CF, from the least to the most isolated, and CF is required for anything applied directly to the heart. Under normal conditions, patient leakage current is limited to 100 µA for types B and BF and 10 µA for type CF, rising to 500 µA and 50 µA with a single fault. Earth leakage from the equipment is limited to 5 mA normally and 10 mA with a fault.
Those limits concern low-frequency current, which is dangerous because it can disturb the heart. A surgical generator also has a high-frequency limit of its own, for a different harm. Its output is meant to deliver current to the patient, so the relevant question is how much high-frequency current escapes by paths other than the intended return, through stray capacitance to earth. IEC 60601-2-2 limits that, for monopolar outputs, to 150 mA, measured through a 200 Ω resistor that stands in for a person, a limit three to four orders of magnitude above the patient-leakage limits. At several hundred kilohertz the risk is a burn, not fibrillation. One manufacturer declares under 100 mA for its monopolar outputs.
Software and cybersecurity
Modern generators are defined as much by software as by hardware: the closed-loop algorithms of Chapters 9 and 10, the end-point detection that decides when a seal is finished, the safety checks and the user interface. Software development follows IEC 62304, the standard for medical device software life-cycle processes. In the US, FDA's 2023 guidance on software in premarket submissions sorts devices into two documentation levels, Basic and Enhanced, replacing the earlier Levels of Concern. FDA's electrosurgical guidance says that general-surgery electrosurgical devices should generally address the Enhanced level.
Connectivity adds a newer obligation. Since 2023, section 524B of the US Federal Food, Drug, and Cosmetic Act has required manufacturers of "cyber devices", devices with software that can connect to the internet and could be vulnerable, to submit a plan for monitoring and addressing vulnerabilities, to maintain processes for updates and patches, and to provide a software bill of materials. A generator with a network or service interface is likely to qualify. The public summary for the 2025 clearance of one generator, discussed in Chapter 21, notes an added service interface and a cybersecurity assessment performed according to FDA guidance.
Risk and use
All of this is organized by risk management under ISO 14971, which requires the manufacturer to identify hazards, estimate and control their risks, and show that what remains is acceptable. Many of the hazards in Chapters 8 and 18 to 19 appear in a generator's risk file: burns at the pad and away from the tip, fire, interference with implants, unintended activation. Some are controlled in the hardware and software, such as the pad monitor and the safety channel; others are controlled by labeling and training.
Usability engineering under IEC 62366-1 connects the two. The knowledge-test results of Chapter 18 show that trained surgeons do not always know how their energy devices fail. A design that tolerates predictable errors, for instance by refusing to operate with a single-plate pad in a mode that needs a split one, controls risk more reliably than a warning in the instructions.
The safety architecture of a generator follows one rule: no single failure, whether of a component, the software or the user, may deliver energy that was not intended. The second channel, the insulation barriers, the pad monitor, the software process and the usability work are that rule applied to different kinds of failure.
- IEC 60601-1 requires basic safety and essential performance; for a generator, essential performance means accurate output and no unintended output.
- Generators use an independent safety channel that can disable the power stage even if the controller fails.
- Insulation barriers and leakage limits protect against low-frequency current in microamperes; a separate limit, 150 mA through 200 Ω for monopolar outputs, governs high-frequency leakage, which causes burns.
- Software follows IEC 62304 at FDA's Enhanced documentation level; connected generators carry cybersecurity obligations; ISO 14971 and IEC 62366-1 organize the rest.
Compliance testing.
+ The questionWhat does compliance testing actually check on a surgical generator, and what does a public test record show?
The standards stack
A surgical energy device is tested against a stack of standards, each covering a different layer of the problem. At the base are process standards, which govern how the device is designed and made rather than what it does: ISO 13485 for the quality management system, ISO 14971 for risk management, IEC 62304 for software, IEC 62366-1 for usability and IEC 81001-5-1 for security in the software life cycle. Above them is the general standard for medical electrical equipment, IEC 60601-1, now at edition 3.2 of 2020. Collateral standards add requirements shared by many devices: IEC 60601-1-2 for electromagnetic compatibility, IEC 60601-1-6 for usability and IEC 60601-1-8 for alarms.
On top sit the particular standards, one for each type of equipment, which modify and override the general standard where they differ. For electrosurgery it is IEC 60601-2-2; for lasers IEC 60601-2-22; for high-intensity therapeutic ultrasound IEC 60601-2-62; for endoscopic equipment, which applies to many laparoscopic instruments, IEC 60601-2-18. Some energies also have product standards for measuring output: IEC 61847 for measuring and declaring ultrasonic output, and IEC 60825-1 for classifying laser products by hazard.
The stack has a gap worth knowing about. No particular IEC 60601-2 standard for ultrasonic surgical systems was found for this guide. Ultrasonic generators are tested to IEC 60601-1 and, where they also deliver bipolar current, to IEC 60601-2-2; IEC 61847, updated in 2025 to cover 20–120 kHz, describes how to measure and declare their output but explicitly does not deal with effectiveness or safety, and appears to exclude clamp-type devices such as ultrasonic shears.
Editions matter, because regulators recognize specific ones. FDA's database of recognized consensus standards added IEC 60601-2-2 edition 6.1, a 2023 consolidation corrected in November 2025, on 25 May 2026, while the earlier edition 6.0 remains listed. For IEC 61847, FDA still recognizes only the 1998 edition; for IEC 60825-1, the database lists the 2007 edition, although Laser Notice 56 lets laser makers conform to the 2014 edition (Chapter 19); and the April 2026 amendment to IEC 60601-2-22 is not yet recognized. IEC 62304's second edition, once expected in 2026, is now listed for about October 2028.
Bench tests for a surgical generator
IEC 60601-2-2 adds a set of tests specific to electrosurgery on top of the general electrical-safety, temperature and EMC tests of IEC 60601-1 and 60601-1-2. Three of them follow directly from earlier chapters.
Output against load. The generator drives a bank of non-inductive resistors covering the load range, from tens of ohms to about 2,000 Ω, while a power meter records the output. The results are the curves of Chapter 10, at maximum and half setting, and the declared waveforms at rated load. The 2023 amendment kept its rule on output reduction and separated scenarios for simultaneous activation.
High-frequency leakage. The generator stands on an insulating table with its electrodes arranged as the standard specifies, and any current escaping to earth is measured through a 200 Ω non-inductive resistor, the stand-in for a person. The limit for monopolar outputs is 150 mA, and the same limit applies to current that couples into an output that is not activated while another output is. The 2023 amendment requires each electrode to be tested first with the output unloaded and then loaded at rated load.
Return electrode heating. A return pad is placed on a test subject or phantom and carries a set current, quoted for the standard's fifth edition as 700 mA for pads intended for patients over 15 kg, 500 mA for 5–15 kg and 350 mA for under 5 kg, while the skin beneath is watched. The temperature rise must not exceed 6 °C. The amendment requires heating under the return electrode to be evaluated even for outputs below the 30 A²s high-current threshold.
The accessories are tested too. Active accessories, such as pencils and laparoscopic electrodes, face a high-frequency dielectric test at 120 % of their rated voltage for 30 seconds, with a test waveform whose crest factor must be no more than 2 up to 1,600 V peak, and then rises with the rating. They also face a leakage test through their insulation. The amendment added a requirement that the instructions state the length of each accessory.
Tissue and animal testing
Standards test the electrical device; they do not show what it does to tissue. FDA's guidance for electrosurgical devices in general surgery fills that gap. For a general soft-tissue claim, it expects thermal effects to be measured in at least three tissues, such as liver, kidney and muscle; the length, width and depth of the thermal damage zone to be measured under magnification with histological stains; the tests to cover best-case, realistic and worst-case temperature-time histories; and each condition to be run in triplicate at minimum, default and maximum settings. It adds animal testing where needed, a chronic animal study for claims about specific tissues or sites, capacitive-coupling tests for monopolar instruments used in minimally invasive surgery, biocompatibility, sterility and reprocessing, and labeling warnings, among them smoke evacuation and hybrid trocars. Vessel sealers add the burst-pressure and chronic-animal requirements of Chapter 9.
Compliance testing and performance testing answer different questions. The IEC tests show that a generator is electrically safe and delivers what it declares. The tissue and animal tests show what that output does to a patient. A device needs both, and a report of one is not evidence of the other.
Reading one public record
Much of this evidence stays in the manufacturer's submission, but a 510(k) summary is public, and reading one closely shows what it can and cannot tell an outsider. Take K251108, the Erbe VIO 3n electrosurgical generator with accessories, cleared by FDA on 29 August 2025 under product code GEI, 21 CFR 878.4400, Class II.
The summary names its predicates: primarily K240932, a 2024 clearance whose summary is titled "HybridTherm System" and includes the VIO 3 generator, and secondarily the older VIO 300 D. It describes the device: monopolar and bipolar cutting and coagulation modes, a maximum output of 360 W and a frequency of 350 kHz, and five named configurations. It lists the differences from the predicate: a new software version, an added service interface and five configurations instead of one. And it lists the testing: functional testing and design controls, side-by-side tissue testing according to FDA's electrosurgical guidance, EMC to IEC 60601-1-2, electrical safety to IEC 60601-1 and IEC 60601-2-2, software verification at the Enhanced documentation level in compliance with IEC 62304, and a cybersecurity assessment according to FDA guidance. No clinical data were needed.
Read against this guide, the record makes sense. Each difference from the predicate is matched by testing in the summary: the new software by software verification, the new service interface by a cybersecurity assessment, and the new configurations by functional and tissue testing. What the summary does not show is equally instructive. It does not name the editions of the standards, show the output curves or give any tissue measurements. Those are in the submission, which FDA reviewed and the public cannot see.
A second record shows how the framework has moved. K213696, a Megadyne generator from Ethicon cleared in January 2022, reduced the maximum power of its predicate, cited IEC 60601-2-18 alongside the core standards, reported thermal testing in triplicate at minimum, default and maximum settings, and documented its software for a "Major" Level of Concern, the framework FDA replaced in 2023.
A 510(k) summary is a map of the evidence, not the evidence. Use it to learn a device's classification, its predicates, what changed and which families of tests were run. Do not use it to compare performance between devices: the numbers that would allow that are almost never in the summary.
- Compliance rests on a stack: process standards, the general IEC 60601-1, collaterals for EMC, usability and alarms, particular standards per energy, and product output standards.
- IEC 60601-2-2 adds electrosurgery tests: output against load, high-frequency leakage through 200 Ω, return-electrode heating of no more than 6 °C, and accessory insulation.
- FDA guidance adds tissue testing in three tissues at three settings in triplicate, animal studies where needed, and capacitive-coupling tests.
- A public 510(k) summary shows classification, predicates, differences and test families, but not the data; FDA recognizes specific standard editions, which lag publication.
Regulation in the US, the EU and India.
+ The questionWhat does it take to sell a surgical energy device in the United States, the European Union and India, and what happens when you change it?
The United States: classification decides the route
In the US, what a device must prove depends first on its classification, and the energies in this guide fall into several regulations. An electrosurgical cutting and coagulation device, defined as one intended to remove tissue and control bleeding with high-frequency current, is Class II under 21 CFR 878.4400, product code GEI. Such devices reach the market through a 510(k), a premarket notification showing that the device is substantially equivalent to a legally marketed predicate, and GEI devices are eligible for review by accredited third parties. Surgical lasers for general and plastic surgery and dermatology are Class II under 21 CFR 878.4810, product code GEX, also by 510(k).
Ultrasonic surgical instruments are an anomaly. Product code LFL is still listed as unclassified, a device type on the market before the 1976 amendments that created the classification system, and it too requires a 510(k). At a panel meeting in October 2022, FDA proposed classifying ultrasonic surgical instruments as Class II with special controls; its briefing noted more than 46,000 medical device reports for the product code between 2002 and 2021, most of them malfunction reports. As of September 2026, the product-code page still reads unclassified. Hybrid instruments that combine bipolar and ultrasonic energy have been cleared under the electrosurgical regulation with both product codes.
The first device of a new kind has no predicate, and so no 510(k). If its risk is low or moderate, its maker can request a De Novo classification, which creates a new regulation that later devices can follow. The ablation chapters met three examples: the Sonablate HIFU system in 2015, histotripsy for liver tumors in 2023 and cryoablation for low-risk breast cancer in 2025. The pattern after Sonablate shows how the route works: once the De Novo existed, a competitor withdrew its own De Novo request and filed a 510(k) with Sonablate as its predicate. Higher-risk devices go through premarket approval instead; the pulsed field ablation systems for atrial fibrillation were approved by FDA rather than cleared.
Whatever the route, the manufacturer must run a quality system. Since 2 February 2026, the US Quality Management System Regulation has incorporated ISO 13485:2016 by reference, replacing the older Quality System Regulation and aligning US requirements with the international standard. Recognized consensus standards, the software documentation level and the cybersecurity requirements of Chapter 20 complete the picture.
The European Union: Rule 9
Under the EU Medical Device Regulation, classification follows rules in Annex VIII. Rule 9 covers active therapeutic devices that administer or exchange energy. They are Class IIa unless they may administer energy in a potentially hazardous way, considering the nature, density and site of application of the energy, in which case they are Class IIb. The Medical Device Coordination Group's classification guidance, MDCG 2021-24, gives the examples directly: high-frequency electrosurgical generators and electrocautery equipment including their electrodes, surgical lasers, surgical ultrasound devices and high-intensity focused ultrasound are all Class IIb. A revision in April 2026 is reported not to have changed Rule 9.
A Class IIb device needs a notified body. Under the usual route in Annex IX, the notified body audits the manufacturer's full quality management system and assesses the technical documentation of at least one representative device in each generic device group; a type-examination route is also available. When the assessment is complete, the manufacturer affixes the CE marking.
The EU is still in transition. Regulation 2023/607 extended the validity of certificates issued under the older directives to the end of 2027 or 2028, depending on the class, for manufacturers that met its conditions. In December 2025 the Commission proposed targeted simplifications, including risk-proportionate certificate reviews and remote audits; as of September 2026 the proposal had not been adopted, as far as could be confirmed.
India: the Medical Devices Rules
India regulates devices under the Medical Devices Rules, 2017, which set four risk classes, A to D. The regulator, CDSCO, publishes classification lists by specialty. Its 2021 lists place general-purpose electrosurgical units and laser surgical instruments, including CO₂ lasers, in Class C, moderate to high risk. No published class for ultrasonic surgical systems was found for this guide; Class C would be consistent with the others, but it should be confirmed.
Class C devices are licensed centrally. A manufacturer applies on Form MD-7 for a manufacturing license on Form MD-9; an importer applies on Form MD-14 for an import license on Form MD-15. Rule 7 sets the order of standards a device must meet: standards of the Bureau of Indian Standards first, then international standards such as those of the IEC and ISO where no Indian standard exists, then validated manufacturer's standards. CDSCO has been revising its specialty classification lists since late 2025, so the current list should be checked for any device.
One core, three wrappers
The three systems ask different questions in different forms, but they draw on the same body of evidence: a quality management system to ISO 13485, a risk management file to ISO 14971, IEC 60601 test reports, software documentation to IEC 62304, usability files, and the performance testing of Chapter 21. A manufacturer that builds that core once, and keeps it current, can present it to each regulator in the form that regulator asks for. One that builds it separately for each market repeats most of the work.
When the device changes
A device is cleared or certified as it was described. Every later change, to its software, its components, its labeling or its materials, has to be assessed against that description.
In the US, FDA's 2017 guidance on deciding when to submit a 510(k) for a change walks through labeling, technology, performance and material changes with flowcharts. The central question is whether the change could significantly affect safety or effectiveness, or is a major change in the intended use; if so, a new 510(k) is needed, and if not, the assessment is documented in the quality system. Software changes have a companion guidance. Both records of Chapter 21 are new models cleared against a predicate. Each difference from the predicate, such as the VIO 3n's new software, service interface and configurations or the Megadyne generator's lower maximum power, is matched by testing in its summary; the summaries do not say which difference made the new 510(k) necessary.
In the EU, Annex IX requires the notified body's approval for changes to an approved device that could affect its safety or performance or the conditions of use, given as a supplement to the certificate or after a new assessment, and planned substantial changes to the quality system or the device range must be notified in advance.
The words are not interchangeable. In the US, a 510(k) device is cleared, a De Novo request is granted and a premarket approval device is approved. In the EU, the notified body assesses the manufacturer and issues the certificates, including the one covering the quality system, and the manufacturer affixes the CE marking. Voluntary ISO 13485 certificates come from accredited certification bodies. Using the wrong word in a submission or a claim is an avoidable error.
Write the intended use and the list of claims first, then classify the device in each target market, and only then plan the evidence. The same generator with a vessel-sealing claim, a general-surgery claim or a claim for a specific organ can need different tissue tests, animal studies and even routes. A change plan that names, for each foreseeable change, whether it triggers a new submission saves time later.
- In the US, electrosurgical and laser devices are Class II by 510(k); ultrasonic instruments remain unclassified; new kinds of device use De Novo; the highest-risk ones need premarket approval.
- In the EU, energy devices that act in a potentially hazardous way are Class IIb under Rule 9 and need notified-body assessment of the quality system and technical documentation.
- In India, electrosurgical units and surgical lasers are Class C, licensed centrally on Forms MD-9 or MD-15, with Indian standards taking precedence.
- The same core of quality, risk and test evidence serves all three; each change must be assessed against each market's test for a new submission or approval.
The frontier.
+ The questionWhat is changing in surgical energy, and what is likely to stay hard?
Non-thermal ablation goes mainstream
The largest change of the last three years is non-thermal ablation. Pulsed field ablation has become routine for atrial fibrillation, and histotripsy has entered clinical use for liver tumors. Chapter 15 traced pulsed field ablation from its first US approval in December 2023 to most of the spending on atrial fibrillation catheters in the US by 2025, with one system's registry of more than 17,000 patients showing no esophageal complications. In tumor ablation, histotripsy received its first US authorization, for liver, in October 2023, and its maker announced a De Novo request for kidney in May 2026; the clearance of one IRE system was extended to name prostate tissue in December 2024. Cryoablation, not new, gained a US indication in low-risk breast cancer in October 2025.
What pulsed fields and histotripsy share is the idea from Chapter 6: that for some tasks, the side effect of heat, destroying collagen scaffolds, matters more than its effectiveness. The question for the next few years is how far that idea extends beyond the heart and liver, and what evidence a new indication will need.
Standards and regulation in motion
The rules are moving as fast as the devices. The US Quality Management System Regulation, in force since February 2026, brought ISO 13485 into US law. FDA recognized the consolidated edition 6.1 of IEC 60601-2-2 in May 2026. IEC 61847 was rewritten in 2025 to cover ultrasonic systems up to 120 kHz, but FDA still recognizes its 1998 edition. An amendment to the laser standard IEC 60601-2-22 was published in April 2026 and is not yet recognized. The second edition of IEC 62304 has slipped to about October 2028, and the fourth edition of IEC 60601-1 is still in draft, with a committee draft for vote expected about late 2028. In the EU, a proposed simplification of the Medical Device Regulation had not been adopted as of September 2026, as far as could be confirmed, and in the US the classification of ultrasonic surgical instruments, proposed in 2022, is still pending.
For a manufacturer, this means that a device's compliance is a moving target even when the device does not change. Recognized editions change, transition periods end, and a test report that was sufficient at clearance may need updating before the next submission.
Robotic energy
Robotic surgery is changing how energy is delivered as much as where. Intuitive's integrated E-200 generator powers its vessel sealers and SynchroSeal, the energy system and the robot are designed together, and the manufacturer describes force feedback on instruments of its newest system. Medtronic's Hugo system lists LigaSure RAS Maryland as its energy instrument, and its US indication is currently limited to urologic procedures. As the robot takes over more of what the surgeon's hand once did, the questions of Chapter 7 grow: which controller decides when energy flows, how the two systems are verified together, and how reused wristed instruments keep their insulation.
Lasers and power electronics
In urology, thulium fiber lasers now compete directly with holmium for stones and prostate work. The engineering difference is efficiency: a diode-pumped fiber laser converts several times more of its mains power into light, can be air-cooled, and, according to one manufacturer, runs from a standard wall outlet. Pulse shaping for holmium lasers continues to develop in response. Across the energies, the direction of power electronics is similar: smaller, more efficient, more digitally controlled sources, with the software and cybersecurity obligations that come with them.
What stays hard
Some problems in this guide are not going away, because they come from physics rather than from technology.
The effect is still inferred, not measured. A sealer infers a seal from impedance; an RF ablation generator infers a zone from temperature or impedance; the margin of an ablation is judged afterwards on a scan. Direct, real-time measurement of the tissue effect remains rare. MRI thermometry during focused ultrasound, the bubble cloud of histotripsy and the visible ice ball come closest, although the ice ball's visible edge is 0 °C, not the lethal edge.
Energy still escapes out of view. Insulation still fails in reusable instruments, more often in robotic ones, and capacitive coupling is a property of any shaft in a cannula. Monitoring helps; physics does not change.
Tissue still varies. Perfusion, water content, collagen content and large vessels change what a given output does. Bench tests in unperfused tissue will always show the best case.
Evidence is still hard to compare. Many performance studies are written or funded by manufacturers, conditions differ between studies, and each device generation changes the answer. Independent, standardized comparisons remain the scarcest evidence in the field.
Regulatory status is still easy to misstate. Filed is not cleared, cleared is not approved, and an indication for a tissue is not an indication for a disease. The frontier is where those distinctions are most often lost.
Every item in this chapter is dated because the field moves. Regulatory decisions, trial results and standards editions are stated as of September 2026. Announcements of filings, launches and future editions are not results, and the difference is worth keeping in every claim, including one's own.
- Since 2023, pulsed field ablation has become routine for atrial fibrillation, histotripsy has entered clinical use for liver tumors, and cryoablation has gained a new indication.
- Standards and regulations are changing on their own schedule: QMSR, IEC 60601-2-2 Ed. 6.1, IEC 61847 Ed. 2, and pending editions and reforms.
- Robotic systems integrate energy with the robot and its controller; thulium fiber lasers bring efficiency gains to urology.
- Measuring the effect directly, containing stray energy, tissue variability, comparable evidence and accurate regulatory claims remain hard.
Lessons.
The chapters reduce to a short set of working rules for anyone who designs, tests, buys, regulates or writes about surgical energy devices. Each one traces back to a mechanism explained earlier.
- State temperature and time together, or state the effect. A temperature alone says little; the injury depends on how long it is held, and the tissue decides how steeply (Chapters 1 and 2).
- Ask where the energy is deposited and how fast. Geometry and speed, set by the carrier and the control, decide cut, seal, coagulation or ablation more than the final temperature does (Chapters 2, 5 and 6).
- Follow the current density. Heat appears wherever current is concentrated, intended or not: at the tip, at a lifting pad edge, at a pinhole in insulation (Chapters 3, 8 and 18).
- Read the waveform, not the power setting. Crest factor and peak voltage decide whether a mode cuts, coagulates or fulgurates, and how strongly it stresses insulation and couples stray current (Chapters 8 and 18).
- Read power-versus-load curves before power ratings. A setting is honored only in the constant-power region, at loads near the rated load (Chapter 10).
- Treat every end point as an inference. Sealers and ablation generators infer the tissue's state from impedance or temperature; the strength of the result is established by testing, not by the tone (Chapters 9, 13 and 17).
- Stay within the indicated vessel size. Seal strength falls sharply beyond it; a mechanical closure does not rely on heating the tissue (Chapters 9 and 17).
- Remember that no current does not mean no hazard. Ultrasonic blades retain heat after activation; a laser's eye-hazard distance can exceed the room; each energy trades one hazard for another (Chapters 11, 12 and 19).
- Plan ablation to the lethal edge, not the visible one. The ice ball's edge is 0 °C, heated zones shrink next to vessels, and manufacturer zone charts are measured without perfusion (Chapters 2, 13 and 14).
- Choose non-thermal energy when the scaffold must survive. Pulsed fields and histotripsy kill cells while sparing collagen-rich vessels and ducts, but they still need their own verification, including of any heating (Chapters 15 and 16).
- Design for the fault as well as the function. An independent safety channel, isolation barriers, pad monitoring and usability engineering keep a single failure from delivering unintended energy (Chapter 20).
- Build one evidence core and present it three ways. A quality system, a risk file, standards test reports and performance testing serve the US, the EU and India alike (Chapters 21 and 22).
- Keep filed, cleared, granted, approved and certified apart. Every regulatory claim names the status, the regulator, the indication and the date (Chapters 16, 22 and 23).
Glossary.
Terms are defined as they are used in this guide.
- 510(k)
- A US premarket notification showing that a device is substantially equivalent to a legally marketed predicate device.
- Ablation
- Destroying tissue in place, usually a tumor, without removing it.
- Absorption coefficient (µa)
- The probability per unit length that light is absorbed; its inverse, 1/µa, is the absorption depth.
- Acoustic impedance
- Density multiplied by the speed of sound. A mismatch at a boundary reflects sound.
- Acoustic window
- A path from the skin to a target that is free of gas and bone, needed for focused ultrasound.
- Active electrode
- The electrode at the working end of an instrument that delivers current to tissue.
- Active electrode monitoring
- A shielded instrument shaft whose shield current is measured to detect insulation failure and excessive capacitive coupling.
- Advanced bipolar sealer
- A bipolar device that combines high jaw pressure, high current at low voltage and closed-loop control to seal vessels, typically up to 7 mm.
- Antinode
- A point of maximum motion in a standing wave. The blade tip of an ultrasonic instrument sits at one.
- Applied part (B, BF, CF)
- The part of a device that contacts the patient, classified by how well it is isolated; type CF is required for direct cardiac contact.
- Arrhenius model
- A description of thermal damage as a chemical reaction whose rate rises exponentially with temperature.
- Basic safety
- Freedom from unacceptable risk from physical hazards in normal use and after a single fault (IEC 60601-1).
- Bioheat equation
- Pennes' heat balance for living tissue: the rate at which stored heat rises equals the heat deposited, plus the net heat conducted in, minus the heat carried off by blood perfusion.
- Bipolar
- Electrosurgery in which both electrodes are in the instrument and current flows only through the tissue between them.
- Blocking capacitor
- A capacitor in series with a generator output that passes high-frequency current and blocks direct and low-frequency current.
- Burst pressure
- The pressure at which a sealed vessel fails when filled with liquid; the bench test of seal strength.
- Butterworth–Van Dyke model
- The equivalent circuit of a piezoelectric transducer: its own capacitance in parallel with a resonant branch representing mass, stiffness and losses.
- Capacitive coupling
- Transfer of alternating current across an insulator without contact, for example from an instrument shaft to a metal cannula.
- Carbonization
- Charring of tissue that has dried out, from roughly 150–200 °C; it raises impedance and releases smoke.
- Cavitation
- The formation of bubbles in a sound field. Stable bubbles oscillate; inertial bubbles collapse violently and damage tissue.
- CEM43
- Cumulative equivalent minutes at 43 °C, a thermal dose. Above 43 °C, each degree roughly halves the time needed for the same effect.
- Chromophore
- A molecule that absorbs light, such as water, hemoglobin or melanin.
- Coagulation
- Irreversible unfolding of proteins by heat, which kills cells and stops bleeding from small vessels.
- Contact quality monitoring
- Measurement of the impedance between the two halves of a split return pad, stopping the output if the pad lifts.
- Crest factor
- Peak voltage divided by RMS voltage. It is low for cutting waveforms and high for fulguration and spray coagulation.
- Cryoablation
- Destroying tissue by freezing it.
- De Novo
- A US route that classifies a new kind of low- or moderate-risk device with no predicate, creating a regulation later devices can follow.
- Desiccation
- Drying of tissue by relatively slow heating, which forms a coagulum without vaporizing it.
- Dielectric heating
- Heating by polar molecules, mainly water, turning in an alternating electromagnetic field and lagging behind it.
- Diffusion length
- The distance heat spreads in a time t, about √(4αt), where α is the thermal diffusivity.
- Direct coupling
- Current passing from an active electrode into another conductor it touches, and from there into tissue.
- Duty cycle
- The fraction of time a waveform is switched on.
- Electroporation
- The opening of pores in cell membranes by an induced membrane voltage; reversible if the cell recovers, irreversible if not.
- Essential performance
- Performance needed to avoid unacceptable risk, identified by the manufacturer (IEC 60601-1). For a generator, accurate and only intended output.
- Fulguration
- Charring of a tissue surface by high-voltage arcs across an air gap, without contact.
- Heat sink
- Cooling of the tissue around a large vessel by the blood flowing through it.
- Heating factor
- Current squared multiplied by time. An output that can exceed 30 A²s in any 60 seconds is a high current mode under IEC 60601-2-2.
- HF leakage current
- High-frequency current escaping from an electrosurgical output by paths other than the intended return; limited to 150 mA through 200 Ω for monopolar outputs.
- HIFU
- High-intensity focused ultrasound, which heats a small focal volume deep inside tissue.
- Histotripsy
- Mechanical destruction of tissue by focused ultrasound pulses that cause inertial cavitation, with little heating.
- Hybrid cannula
- A metal cannula held in a plastic anchor. It can collect capacitively coupled current and discharge it into bowel.
- Hybrid instrument
- An instrument that combines two energies in one jaw, such as bipolar and ultrasonic.
- Impedance roll-off
- The fall in RF power delivery when tissue at an electrode dries and chars and stops conducting.
- Irreversible electroporation (IRE)
- Tumor ablation by electric pulses that open membrane pores the cells cannot repair.
- Isolated output
- A generator output isolated from earth, so that current returns mainly through its own return lead; paths to earth are high impedance, not absent.
- Joule heating
- Heating by current flowing through a resistance; in tissue, J²/σ per unit volume.
- Joule–Thomson effect
- The temperature change of a real gas expanding through an orifice without doing work. Argon cools; helium, at room temperature, warms.
- Langevin stack
- Piezoelectric rings clamped between two masses by a bolt; the transducer of an ultrasonic instrument.
- Lateral thermal spread
- Thermal damage beyond the tissue a device was meant to affect, measured by histology.
- Lethal isotherm
- In cryoablation, the temperature line, about −20 to −40 °C, inside which cells reliably die.
- Means of protection
- Insulation, clearance and creepage that protect the operator (MOOP) or the patient (MOPP) from hazardous voltage.
- Monopolar
- Electrosurgery in which current flows from an active electrode through the patient to a return pad.
- Motional current
- The current in the resonant branch of a piezoelectric transducer, proportional to blade velocity at resonance.
- Node
- A point of no motion in a standing wave. The supports of an ultrasonic waveguide sit at nodes.
- Nominal ocular hazard distance
- The distance along the direct beam beyond which exposure falls below the eye's maximum permissible exposure. Reflections and focusing optics define a wider nominal hazard zone.
- Notified body
- An organization designated in the EU to assess the conformity of medical devices.
- Particular standard
- A standard for one type of medical electrical equipment that modifies and overrides the general standard, such as IEC 60601-2-2.
- Piezoelectric effect
- The change of shape of certain crystals and ceramics under an applied voltage, and the voltage they produce when strained.
- Population inversion
- More atoms in an excited laser level than in the level below it, the condition for amplification by stimulated emission.
- Predicate device
- A legally marketed device to which a new device is shown to be substantially equivalent in a 510(k).
- Pulsed field ablation (PFA)
- Cardiac ablation by electroporation, usually with short biphasic pulses.
- Rated load
- The load resistance at which a generator mode's power and waveform are specified.
- Return electrode
- The large pad that returns monopolar current to the generator; also called the dispersive or neutral electrode.
- Thermal relaxation time
- The time a heated layer takes to lose its heat by conduction, about L²/4α for a layer of thickness L.
- Vaporization
- Explosive boiling of the water in cells, the mechanism of electrosurgical and many laser incisions.
Sources.
Sources are listed by the chapter in which they are first used. Figures from manufacturers, and from studies written by manufacturers' staff, are identified as such in the text. Regulatory status and standards editions are as of September 2026.
- Ch. 1 — Pearce J.A. Arrhenius models of thermal damage: workshop notes. IEEE EMBS (2015). embs.org/wp-content/uploads/2016/08/ws2015_5_Pearce_notes.pdf
- Ch. 1 — Sapareto S.A., Dewey W.C. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10, 787–800 (1984).
- Ch. 1, 5 — Niemz M.H. Laser-Tissue Interactions, Chapter 3. Springer.
- Ch. 1 — Palanker D., Vankov A., Jayaraman P. On mechanisms of interaction in electrosurgery. New J Phys 10, 123022 (2008).
- Ch. 1 — Dargent D., Schettini S. Physical bases of electrosurgery. Contemporary OB/GYN (2005).
- Ch. 1 — Holmes K.R. Thermal properties of biological tissues (compilation). users.ece.utexas.edu/~valvano/research/Thermal.pdf
- Ch. 1, 2, 7, 10, 18, 21 — US FDA. Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery. Guidance (2016; current version 9 March 2020). fda.gov/media/87995/download
- Ch. 2 — Guntur S.R. et al. Temperature-dependent thermal properties of ex vivo liver undergoing thermal ablation. Ultrasound Med Biol (2013).
- Ch. 2 — Berjano E.J. Theoretical modeling for radiofrequency ablation: state-of-the-art and challenges for the future. BioMed Eng OnLine 5, 24 (2006).
- Ch. 2 — Hall J.E. Guyton and Hall Textbook of Medical Physiology, 12th ed., Chapter 17 (2011).
- Ch. 2, 13 — Lu D.S.K. et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the heat sink effect. AJR 178, 47–51 (2002).
- Ch. 2 — Lu D.S.K. et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol (2003).
- Ch. 2, 9 — Chambers L.W., Sarno D., Roweton S. New bipolar electrosurgical vessel sealing device provides improved performance and procedural efficiency. Med Devices (Auckl) (2025). Authors employed by the manufacturer.
- Ch. 3 — Gabriel S., Lau R.W., Gabriel C. The dielectric properties of biological tissues: III. Parametric models for the dielectric spectrum of tissues. Phys Med Biol 41, 2271–2293 (1996).
- Ch. 3 — Engineering and Technology History Wiki. Biological effects of electromagnetic radiation (on d'Arsonval, 1891). ethw.org
- Ch. 3, 8, 10, 18, 20, 21 — IEC 60601-2-2: Particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency surgical accessories. Ed. 6.0 (2017) and AMD1 (2023); consolidated Ed. 6.1, corrected version 2025-11.
- Ch. 3, 15 — Kotnik T., Pucihar G. Induced transmembrane voltage: theory, modeling, and experiments. In Advanced Electroporation Techniques in Biology and Medicine, 51–70 (2010).
- Ch. 3, 8 — Woloszko J., Marion D. Method and system of reduction of low frequency muscle stimulation during electrosurgical procedures. US 2011/0245826 A1 (filed 2010).
- Ch. 4 — Culjat M.O. et al. A review of tissue substitutes for ultrasound imaging. Ultrasound Med Biol 36, 861–873 (2010).
- Ch. 4, 16 — Vlaisavljevich E. et al. Effects of ultrasound frequency and tissue stiffness on the histotripsy intrinsic threshold for cavitation. Ultrasound Med Biol (2015).
- Ch. 4, 11 — van Swol C.F.P. et al. Proc SPIE (1998), high-speed and thermal imaging of an ultrasonic aspirator. doi.org/10.1117/12.304333
- Ch. 4, 11 — Vieira-Coimbra M., Ferreira H. Ultrasonic surgical aspiration (CUSA) for laparoscopic excision of endometriosis. Front Surg 12, 1735940 (2025).
- Ch. 5 — Hale G.M., Querry M.R. Optical constants of water in the 200 nm to 200 µm wavelength region. Appl Opt 12, 555–563 (1973); data via omlc.org/spectra/water.
- Ch. 5 — Prahl S. Tabulated molar extinction coefficient for hemoglobin in water (1998). omlc.org/spectra/hemoglobin
- Ch. 5 — Pang et al. Laser energy in oral soft tissue applications (position paper). J Laser Dent 20(2) (2012).
- Ch. 6, 21, 23 — IEC 61847: Ultrasonics — Surgical systems — Measurement and declaration of the basic output characteristics. Ed. 2.0 (2025).
- Ch. 6, 19, 21, 23 — IEC 60601-2-22: Particular requirements for surgical, cosmetic, therapeutic and diagnostic laser equipment. Ed. 4.0 (2019) and AMD1 (2026).
- Ch. 6, 16, 21 — IEC 60601-2-62: Particular requirements for high intensity therapeutic ultrasound (HITU) equipment. Ed. 1.0 (2013).
- Ch. 7, 8 — Yale Cushing/Whitney Medical Library. Electrosurgical in the operating room (2014). library.medicine.yale.edu
- Ch. 7, 17, 23 — Intuitive. da Vinci instruments: vessel sealers and SynchroSeal, powered by the E-200 generator (accessed September 2026). intuitive.com
- Ch. 7, 18 — Espada M. et al. Insulation failure in robotic and laparoscopic instrumentation: a prospective evaluation. Am J Obstet Gynecol (2011).
- Ch. 7, 11 — Olympus. THUNDERBEAT II and cordless transducer launch, news release (21 October 2025). olympus-global.com
- Ch. 8, 10 — Anderson R.K. (Valleylab). US Patent 3,699,967, an all-solid-state electrosurgical generator with isolated outputs (filed 1971, granted 1972).
- Ch. 8, 19 — Rey J.F., Beilenhoff U., Neumann C.S., Dumonceau J.M. European Society of Gastrointestinal Endoscopy (ESGE) guideline: the use of electrosurgical units. Endoscopy 42, 764–771 (2010).
- Ch. 8 — Romeo A. et al. Electrosurgery: heating, sparking and electrical arcs. Facts Views Vis ObGyn 16(3), 281–290 (2024).
- Ch. 8, 9, 10, 20 — Medtronic. Valleylab FT10 Energy Platform specification sheet (November 2023). Manufacturer data.
- Ch. 8, 20 — Newton D.W., Hulett C., Ovens T. (Valleylab). Return electrode monitoring system for use during electrosurgical activation. US Patent 4,416,277 (filed 1981, granted 1983).
- Ch. 8 — Nessler N., Reischer W., Salchner M. Test device for electrosurgical neutral electrodes. IMEKO TC4 Symposium (2002), citing AAMI HF18.
- Ch. 8 — Megadyne. Universal self-limiting electrosurgical return electrode. US Patent 10,085,791 B2 (2018).
- Ch. 8, 10 — Valleylab. Force EZ-C electrosurgical generator user and service manual (2008); Force FX service manual. Manufacturer documents.
- Ch. 8, 18 — Fuchshuber P., Madani A., Jones D., Schwaitzberg S. The FUSE Program: Promoting Operating Room Safety. Bariatric Times 11(10) (2014); SAGES FUSE program page.
- Ch. 9 — US FDA. 510(k) K981916, LigaSure Vessel Sealing System (cleared 28 August 1998); 510(k) summary K043273 (2005).
- Ch. 9, 21 — US FDA. Premarket Notification (510(k)) Submissions for Bipolar Electrosurgical Vessel Sealers for General Surgery. Guidance (August 2016). fda.gov/media/87987/download
- Ch. 9 — Okhunov Z. et al. Evaluation and comparison of contemporary energy-based surgical vessel sealing devices. J Endourol 32(4) (2018).
- Ch. 9 — Nezhat C. et al. Laparoscopic vessel sealing devices. In Prevention and Management of Laparoendoscopic Surgical Complications, 3rd ed., SLS (2021).
- Ch. 10 — Covidien. US Patent 9,839,470 B2, an electrosurgical generator power chain (granted 12 December 2017).
- Ch. 10 — Friedrichs D.A., Erickson R.W., Gilbert J. A new dual current-mode controller improves power regulation in electrosurgical generators. IEEE Trans Biomed Circuits Syst 6(1), 39–44 (2012).
- Ch. 10 — Rafiq M., Ibeas A., Ullah N. Expert knowledge-based peak current mode control of electrosurgical generators. J Electr Bioimpedance (2023).
- Ch. 11 — Ethicon. Generator G11 (GEN11) operator's manual (2015); ULTRACISION Harmonic Scalpel service manual (1999). Manufacturer documents.
- Ch. 11 — Ethicon. Surgical generator for ultrasonic and electrosurgical devices. US Patent 9,060,776 B2 (2015); Ultrasonic transducer for surgical instrument. US Patent 10,420,580 B2 (2019).
- Ch. 11 — He et al. Changes in ultrasonic scalpel performance and characterization following gastric cancer surgery. Surg Endosc (2026).
- Ch. 11 — Homma T. Advances and safe use of energy devices in lung cancer surgery. Gen Thorac Cardiovasc Surg (2022).
- Ch. 11 — Govekar et al. Residual heat of laparoscopic energy devices: how long must the surgeon wait? SAGES abstract (c. 2011).
- Ch. 11 — Ethicon. HARMONIC ACE+7 Shears with Advanced Hemostasis, FDA clearance news release (2013). Manufacturer statement.
- Ch. 11 — Olympus. THUNDERBEAT launch news release (21 March 2012). olympus-global.com
- Ch. 11 — Shibao K. et al. Repeated partial tissue bite with inadequate cooling time for an energy device may cause thermal injury. Surg Endosc 35, 3189–3198 (2021).
- Ch. 11 — Timm et al. Sealing vessels up to 7 mm in diameter solely with ultrasonic technology. Med Devices (Auckl) (2014). Authors affiliated with the manufacturer.
- Ch. 11 — US FDA. 510(k) summaries K111202 (THUNDERBEAT, 2012), K211838 (USG-410, 2021) and K252150 (THUNDERBEAT II, 7 October 2025).
- Ch. 11 — Engineering ToolBox. Sound speed in solids (extensional speed of titanium). engineeringtoolbox.com
- Ch. 12 — Ling S.J., Sanny J., Moebs W. University Physics Vol. 3, section 8.6, Lasers. OpenStax (2016).
- Ch. 12 — Fried N.M. Recent advances in infrared laser lithotripsy. Biomed Opt Express (2018).
- Ch. 12 — Traxer O., Keller E.X. Thulium fiber laser: the new player for kidney stone treatment? World J Urol (2020).
- Ch. 12 — Lumenis / Boston Scientific. Pulse 120H brochure (2024) and operator manual (2021). Manufacturer data.
- Ch. 12, 23 — Olympus. SOLTIVE SuperPulsed laser system specifications and instructions for use (2020). Manufacturer data.
- Ch. 12 — Sánchez-Puy A. et al. New generation pulse modulation in holmium:YAG lasers. J Clin Med 11, 3208 (2022).
- Ch. 12, 19 — Boston Scientific. GreenLight XPS laser system specifications. Manufacturer data.
- Ch. 12 — Aktas A.R. et al. Lasers Med Sci 30, 1583 (2015), comparing 980 nm and 1,470 nm endovenous ablation.
- Ch. 13 — Hong K., Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 21(8 Suppl) (2010).
- Ch. 13 — Lubner M.G., Brace C.L., Hinshaw J.L., Lee F.T. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 21(8 Suppl), S192–S203 (2010).
- Ch. 13, 14 — Hinshaw J.L. et al. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation. RadioGraphics 34(5) (2014).
- Ch. 13 — Simo et al. Microwave ablation using 915-MHz and 2.45-GHz systems: what are the differences? HPB (2013).
- Ch. 13 — US FDA. 510(k) summary K233838, Emprint ablation system (2024); Medtronic Emprint zone reference charts (2021, manufacturer data).
- Ch. 13 — US FDA. 510(k) summary K130399, NEUWAVE Certus 140 (2013).
- Ch. 13 — Ringe K.I. et al. Experimental evaluation of the heat sink effect in hepatic microwave ablation. PLOS One 10(7), e0134301 (2015).
- Ch. 13 — Huang et al. A review of antenna designs for percutaneous microwave ablation. Phys Med 84 (2021).
- Ch. 13 — De Vita E. et al. A review on radiofrequency, laser, and microwave ablations and their thermal monitoring through fiber Bragg gratings. iScience 26(11), 108260 (2023).
- Ch. 13 — Ahmed M. et al. Image-guided tumor ablation: standardization of terminology and reporting criteria, a 10-year update. Radiology (2014).
- Ch. 14 — Erinjeri J.P., Clark T.W.I. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 21(8 Suppl), S187–S191 (2010).
- Ch. 14 — Cornelis A.A., Bodard S., Cornelis F.H. Lethal isotherm ratio to standardize the comparison of cryoablation needles and systems. CVIR Oncology 1, 3 (2025).
- Ch. 14, 22 — US FDA. De Novo decision summary DEN220077, ProSense cryoablation system (granted 3 October 2025).
- Ch. 15 — Kos B. et al. Determination of lethal electric field threshold for pulsed field ablation in ex vivo perfused porcine and human hearts. Front Cardiovasc Med (2023).
- Ch. 15 — Davalos R.V., Mir L.M., Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 33, 223–231 (2005).
- Ch. 15 — de Baere T., Deschamps F. New tumor ablation techniques for cancer treatment (microwave, electroporation). Diagn Interv Imaging 95(7–8) (2014).
- Ch. 15 — AngioDynamics. NanoKnife system user manual, technical specifications. Manufacturer data.
- Ch. 15 — Nielsen K. et al. Anaesthetic management during open and percutaneous irreversible electroporation. Br J Anaesth 113(6), 985 (2014).
- Ch. 15 — Patil et al. Pulsed field ablation: biophysical principles and practical considerations. Indian Pacing Electrophysiol J 26(2), 103–113 (2026).
- Ch. 15, 23 — Ekanem E. et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med (2024).
- Ch. 15 — Medtronic newsroom (13 December 2023; 24 October 2024); Boston Scientific newsroom (31 January 2024); TCTMD reports on Varipulse (November 2024, February 2025).
- Ch. 15 — Guidepoint Qsight. The pulsed field ablation market (25 June 2026); MedTech Dive on a Citi physician survey (16 December 2024).
- Ch. 15, 22 — AngioDynamics. FDA clearance of the NanoKnife system for prostate tissue ablation, news release (9 December 2024).
- Ch. 16, 22 — US FDA. De Novo decision summary DEN150011, Sonablate 450 (granted 9 October 2015).
- Ch. 16, 22 — EDAP TMS. Focal One FDA 510(k) clearance, news release (7 June 2018); MassDevice, 15 October 2015.
- Ch. 16 — Turner J., Cranston D. A review of high-intensity focused ultrasound. Int J Transl Med 4(1), 197–207 (2024).
- Ch. 16, 22 — US FDA. De Novo decision summary DEN220087, HistoSonics Edison system (decision 6 October 2023).
- Ch. 16 — Yu et al. Prospects for clinical translation of histotripsy in liver applications. Quant Imaging Med Surg 16(1), 92 (2026).
- Ch. 16, 23 — HistoSonics. FDA submission for kidney tumors, news release via Business Wire (11 May 2026); company news page (accessed September 2026).
- Ch. 17 — Ibanez Jimenez et al. BMC Surg (2022), preclinical evaluation of the SynchroSeal robotic vessel sealer. Two authors employed by the manufacturer; funded by Intuitive. doi.org/10.1186/s12893-022-01483-5
- Ch. 18 — Wu M.P., Ou C.S., Chen S.L., Yen E.Y.T., Rowbotham R. Complications and recommended practices for electrosurgery in laparoscopy. Am J Surg 179(1), 67–73 (2000).
- Ch. 18 — El-Sayed M., Saridogan E. Principles and safe use of electrosurgery in minimally invasive surgery. Gynecol Pelvic Med (2021).
- Ch. 18 — Homma T., Uehara H., Saji H. Factors affecting insulation failure in reusable surgical devices. Sci Rep 13 (2023).
- Ch. 18 — Newton D.W., Odell R.C., Boyle J. (Electroscope). Electrosurgical apparatus for laparoscopic and like procedures. US Patent 5,312,401 (filed 1991, granted 1994).
- Ch. 18 — Feldman L.S. et al. Surgeons don't know what they don't know about the safe use of energy in surgery. Surg Endosc 26, 2735–2739 (2012).
- Ch. 18, 21 — MEDTEQ. IEC 60601-2-2 clause 201.8.8.3: HF insulation testing. medteq.net
- Ch. 19 — Liu Y. et al. Awareness of surgical smoke hazards and enhancement of surgical smoke prevention among the gynecologists. J Cancer 10(12), 2788–2799 (2019).
- Ch. 19 — Tomita Y. et al. Mutagenicity of smoke condensates induced by CO2-laser irradiation and electrocauterization. Mutat Res 89, 145–149 (1981).
- Ch. 19 — Casey V.J. et al. Comparison of surgical smoke generated during electrosurgery with aerosolized particulates from ultrasonic and high-speed cutting. Ann Biomed Eng 49, 560–572 (2021).
- Ch. 19 — OSHA. Hospitals eTool: surgical suite, smoke plume. osha.gov
- Ch. 19 — NIOSH. Control of smoke from laser/electric surgical procedures. Hazard Controls HC11, DHHS (NIOSH) Pub. 96-128 (1996).
- Ch. 19 — AORN. Surgical smoke-free OR: state legislation (page updated September 2026). aorn.org
- Ch. 19 — Bruley M.E. et al. Surgical fires: decreasing incidence relies on continued prevention efforts. Pa Patient Saf Advis 15(2) (2018).
- Ch. 19 — Bruley M.E., Feldman J. Why limit open oxygen delivery to 30 %? APSF (2025); APSF upper airway management guide for laser airway surgery (1993).
- Ch. 19 — OSHA Technical Manual, Section III, Chapter 6: Laser hazards. osha.gov
- Ch. 19, 21 — US FDA. Laser Products – Conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 (Laser Notice No. 56). Guidance (May 2019); 21 CFR 1040.10 and 1040.11.
- Ch. 19, 21 — IEC 60825-1: Safety of laser products — Part 1: Equipment classification and requirements. Ed. 3.0 (2014).
- Ch. 19 — Crossley G.H. et al. HRS/ASA expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors. Heart Rhythm 8(7), 1114–1154 (2011).
- Ch. 20, 21 — IEC 60601-1: General requirements for basic safety and essential performance. Ed. 3.2 consolidated (2020); IEC 60601-1-2 Ed. 4.1 (2020); IEC 60601-1-8.
- Ch. 20 — Mean Well. MOPP and MOOP in IEC 60601-1 3rd edition, application note (2015); Biomedical Views, IEC 60601-1 leakage currents.
- Ch. 20, 21 — US FDA. Content of Premarket Submissions for Device Software Functions. Guidance (14 June 2023).
- Ch. 20, 23 — US FDA. Cybersecurity in medical devices: quality system considerations and content of premarket submissions. Guidance (February 2026); cybersecurity FAQs on section 524B.
- Ch. 20, 21 — ISO 14971:2019, risk management; IEC 62304:2006+A1:2015, software life cycle; IEC 62366-1:2015+A1:2020, usability; IEC 81001-5-1:2021, security; ISO 13485:2016, quality management.
- Ch. 21 — US FDA. Recognized Consensus Standards database (accessed September 2026). accessdata.fda.gov
- Ch. 21, 22 — US FDA. 510(k) summaries K251108, Erbe VIO 3n with accessories (cleared 29 August 2025); K240932, HybridTherm System (2024); K213696, Megadyne electrosurgical generator (cleared 21 January 2022).
- Ch. 21, 23 — QuickBird Medical. IEC 62304 Edition 2 has been delayed until October 2028 (2026).
- Ch. 21 — WhaleTeq. High-frequency dielectric strength test, application note.
- Ch. 21 — US Patent 12,357,368 (return electrode test currents, as quoted for IEC 60601-2-2 Ed. 5).
- Ch. 22 — US Code of Federal Regulations, 21 CFR 878.4400 and 878.4810 (accessed 2026); FDA product classification database, codes GEI, GEX and LFL.
- Ch. 22 — US FDA. General and Plastic Surgery Devices Panel, executive summary on ultrasonic surgical instruments (26–27 October 2022).
- Ch. 22 — US FDA. Quality Management System Regulation (final rule 2 February 2024; effective 2 February 2026).
- Ch. 22 — US FDA. Deciding When to Submit a 510(k) for a Change to an Existing Device. Guidance (October 2017).
- Ch. 22 — US FDA. Deciding When to Submit a 510(k) for a Software Change to an Existing Device. Guidance (October 2017).
- Ch. 22 — Regulation (EU) 2017/745 on medical devices, Annexes VIII and IX; Regulation (EU) 2023/607.
- Ch. 22 — Medical Device Coordination Group. MDCG 2021-24, Guidance on classification of medical devices (2021; Rev. 1, April 2026).
- Ch. 22 — European Commission. Proposal for a regulation to simplify the rules on medical and in vitro diagnostic devices, COM(2025) 1023 (16 December 2025).
- Ch. 22 — CDSCO. Medical Devices Rules, 2017; risk classification lists for operation theatre (13 September 2021) and dermatology and plastic surgery devices (26 July 2021).
- Ch. 23 — Medtronic. Hugo RAS system (accessed September 2026); Intuitive. da Vinci 5 (accessed September 2026). Manufacturer pages.
- Ch. 23 — In Compliance Magazine. The IEC 60601 family of standards and the 4th edition of IEC 60601-1 (c. 2025).
Take the PDF with you.
Reading online needs no sign-up. For the PDF edition, laid out for print and offline reading, tell us where to send it and we will email you a download link.
Check your inbox.
The download link is on its way to your email. If it has not arrived in a few minutes, check your spam folder or write to info@unplex.tech.
Preview only — nothing was sent
Educational reference material, not engineering, regulatory or clinical advice. Product and company names referenced are the property of their respective owners.
Let's Talk